Other and unspecified myopathies

G6_MYOPOTHUNS

myopathy: a disease of the muscle in which the muscle fibers do not function properly. This results in muscular weakness.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G72.8, G72.9 Hospital discharge: ICD-9 — 3594B\|359[8-9] Cause of death: ICD-10 — G72.8, G72.9 Cause of death: ICD-9 — 3594B\|359[8-9] 2 out of 7 registries used, show all original rules.	4188
4. Check minimum number of events None	4188
5. Include endpoints None	4188
6. Filter based on genotype QC (FinnGen only)	3748

Control definitions (FinnGen only)

Control exclude: G6_MYONEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_MYOPOTHUNS
CONTROL_EXCLUDE	G6_MYONEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G72[8-9]
HD_ICD_9	3594B\|359[8-9]
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G72[8-9]
COD_ICD_9	3594B\|359[8-9]
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified myopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31284	13661	17471
Only index persons	28306	12682	15624
Unadjusted period prevalence (%)
Whole population	0.44	0.39	0.49
Only index persons	0.54	0.47	0.60
Median age at first event (years)
Whole population	68.48	74.18	64.03
Only index persons	68.82	74.39	64.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3748	1568	2180
Unadjusted period prevalence (%)	0.81	0.56	1.00
Median age at first event (years)	67.17	67.32	67.07

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3853: Matched controls
38530

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1AD

NOMESCO Finland

CT of head and brain

3.5

311.0

1959

8868

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.5

307.7

1713

5795

G72.9

ICD-10 Finland

Myopathy, unspecified

2590.9

307.7

1208

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.2

307.7

685

1306

G72.8

ICD-10 Finland

Other specified myopathies

10872.0

307.7

2845

NXL00

NOMESCO Finland

Biopsy of muscle

57.3

302.0

170

T36

ICD-10 Finland

Poisoning by systemic antibiotics

7.2

251.4

398

610

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.7

245.1

503

997

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

49.1

244.6

142

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

47.5

227.4

133

N05AH04

ATC

quetiapine; oral

3.4

224.4

1063

3912

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

63.5

222.7

123

L28

ICPC

Limited function/disability (L)

3.1

220.3

1324

5598

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

7.8

206.7

298

410

N05AH03

ATC

olanzapine; systemic

4.8

199.9

489

1122

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.5

196.2

532

1325

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.7

195.6

1812

9506

A28

ICPC

Limited function/disability NOS

2.9

193.0

1282

5660

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.7

184.2

267

369

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.2

177.7

846

3079

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.0

174.6

559

1570

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.7

165.6

411

950

F10.25

ICD-10 Finland

Alcohol dependence continuous use

9.0

165.1

209

245

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

12.5

163.6

163

136

L89

ICD-10 Finland

Decubitus ulcer and pressure area

7.1

163.4

256

385

N05AA02

ATC

levomepromazine; systemic

5.4

163.0

341

681

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.8

162.1

567

1690

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.8

158.0

988

4164

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.2

155.7

211

269

M60.9

ICD-10 Finland

Myositis, unspecified

19.4

155.6

122

N03AG01

ATC

valproic acid; systemic, rectal

4.3

155.4

432

1090

SPAT1216

SPAT

Assessment of functional ability

2.8

154.2

1010

4355

SPAT1254

SPAT

Administration of medicine

2.8

150.2

928

3875

R53

ICD-10 Finland

Malaise and fatigue

2.5

149.8

1340

6718

F10.24

ICD-10 Finland

Alcohol depence active use

9.0

142.8

179

207

P15

ICPC

Chronic alcohol abuse

6.0

139.9

257

454

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

138.6

639

2257

N07BB01

ATC

disulfiram; oral

5.0

137.8

310

658

M33.2

ICD-10 Finland

Polymyositis

41.9

136.2

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

134.6

1501

8227

N05BA01

ATC

diazepam; systemic, rectal

2.9

134.2

752

2963

N05AF03

ATC

chlorprothixene; systemic

6.6

133.6

220

348

N05AX08

ATC

risperidone; systemic

3.2

131.5

607

2142

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

129.4

1035

4872

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

10.3

128.2

145

146

N03AE01

ATC

clonazepam; systemic

4.0

127.8

395

1073

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.7

127.1

182

247

M60.8

ICD-10 Finland

Other myositis

31.8

124.8

SPAT1234

SPAT

Support of social functional capacity

3.7

122.1

425

1253

N06AX11

ATC

mirtazapine; oral

2.2

121.3

1577

9120

SPAT1229

SPAT

Assessment of need for aid

3.2

119.3

539

1872

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.7

119.1

169

227

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

118.2

812

3535

N05BA04

ATC

oxazepam; oral

2.3

116.6

1266

6777

N05CD07

ATC

temazepam; oral

2.7

116.3

732

3048

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.9

114.6

367

1020

SPAT1172

SPAT

Guidance concerning hydration

5.4

114.1

234

457

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

111.9

874

4036

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

11.8

111.3

114

N06AB04

ATC

citalopram; systemic

2.4

108.5

985

4860

E86

ICD-10 Finland

Volume depletion

4.9

106.8

246

531

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.8

106.3

344

962

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

105.4

688

2906

C03CA01

ATC

furosemide; systemic

2.1

104.8

1694

10504

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

14.6

103.3

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.8

101.9

193

350

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.2

99.8

174

291

N05AH02

ATC

clozapine; systemic

7.4

97.5

144

202

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.4

96.0

381

1217

N17.8

ICD-10 Finland

Other acute renal failure

7.1

95.4

146

213

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

95.2

876

4318

G71.9

ICD-10 Finland

Primary disorder of muscle, unspecified

+∞

94.1

N03AX09

ATC

lamotrigine; oral

4.2

91.0

254

637

S01.0

ICD-10 Finland

Open wound of scalp

2.8

89.9

513

2013

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.5

89.5

693

3157

N99

ICPC

Neurological disease other

7.2

88.6

133

190

N28

ICPC

Limited function/disability (N)

5.7

88.0

169

310

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.8

88.0

165

296

T68

ICD-10 Finland

Hypothermia

14.0

87.9

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

19.2

86.7

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.5

86.5

216

497

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.2

86.2

377

1275

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.5

85.7

112

136

N03AX16

ATC

[U] pregabalin

2.1

85.7

1058

5840

R41.0

ICD-10 Finland

Disorientation, unspecified

3.9

85.1

261

701

A04

ICPC

Weakness/tiredness general

2.3

84.7

812

4050

F05.9

ICD-10 Finland

Delirium, unspecified

4.6

84.7

207

468

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

9.2

83.9

102

113

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

83.9

753

3652

N04AA02

ATC

biperiden; systemic

6.1

83.8

149

254

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

82.8

508

2064

G71.08

ICD-10 Finland

Other muscular dystrophy

825.9

82.8

A46

ICD-10 Finland

Erysipelas

2.2

82.0

810

4085

M62.8

ICD-10 Finland

Other specified disorders of muscle

17.5

81.7

W19

ICD-10 Finland

Unspecified fall

2.6

81.3

559

2401

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.0

79.7

175

362

N05CF01

ATC

zopiclone; oral

1.9

79.0

1455

9203

N06AX16

ATC

venlafaxine; oral

2.5

78.7

594

2662

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.7

78.4

262

746

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

78.2

389

1413

N05AX12

ATC

aripiprazole; systemic

4.3

75.5

202

490

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.7

75.4

177

387

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

74.9

301

965

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.8

74.7

138

244

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

73.2

872

4711

A06AD11

ATC

lactulose; oral

2.1

73.1

815

4293

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.9

73.0

226

610

N05BA06

ATC

lorazepam; systemic, sublingual

3.1

72.5

323

1101

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

72.3

2100

15212

E87.6

ICD-10 Finland

Hypokalaemia

3.7

72.2

242

690

S06.0

ICD-10 Finland

Concussion

2.4

72.1

552

2484

N05BA02

ATC

chlordiazepoxide; systemic

4.5

71.7

178

407

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.3

71.6

148

290

N03AX12

ATC

[U] gabapentin; oral

2.2

70.4

742

3818

N05AN01

ATC

lithium; oral

5.2

70.3

147

291

M62.9

ICD-10 Finland

Disorder of muscle, unspecified

15.0

70.0

Z2446

NOMESCO Finland

Social worker

2.9

69.7

344

1242

S97

ICPC

Chronic ulcer skin

2.7

68.7

400

1577

N05BE01

ATC

buspirone; oral

4.3

68.6

181

434

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

68.5

518

2315

R60.0

ICD-10 Finland

Localized oedema

2.2

68.3

664

3304

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

67.8

680

3426

N06AX21

ATC

duloxetine; oral

2.4

66.7

527

2401

ZXD05

NOMESCO Finland

Urgent procedure

1.9

66.5

1267

8002

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

7.7

66.2

123

R1250

NOMESCO Finland

Evaluation of functional capability

4.3

66.1

176

425

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

66.0

502

2248

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.5

64.9

466

2031

N05AB03

ATC

perphenazine; systemic, rectal

3.9

64.7

200

539

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.4

64.5

244

752

WX892

NOMESCO Finland

Monitored bed care

2.6

64.5

420

1748

N29

ICPC

Neurological sympt/complt other

4.9

64.2

143

299

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

64.2

408

1678

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

63.4

445

1919

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

63.3

251

797

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.9

62.9

113

TK800

NOMESCO Finland

Hemodialysis

4.6

62.7

154

349

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

62.2

637

3226

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

62.2

568

2747

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

61.7

388

1586

SPAT1301

SPAT

No procedures

1.8

61.5

1328

8672

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

61.2

1197

7582

SPAT1167

SPAT

Insertion of urinary catheter

3.4

60.2

230

713

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.0

59.8

172

440

N05AD01

ATC

haloperidol; systemic

3.5

59.1

209

617

N07AA02

ATC

pyridostigmine; systemic

25.9

58.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

57.8

1432

9693

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.5

57.5

147

N06AB06

ATC

sertraline; oral

2.4

57.4

457

2082

N02AA05

ATC

oxycodone; systemic

1.9

56.3

921

5493

Z72.1

ICD-10 Finland

Alcohol use

6.0

56.0

100

171

N05AC02

ATC

thioridazine; oral

4.9

55.9

126

266

G72.0

ICD-10 Finland

Drug-induced myopathy

+∞

55.3

TNX05

NOMESCO Finland

Simple incision of soft tissue, unspecified region

24.6

55.0

P99

ICPC

Psychological disorders other

4.1

54.8

154

387

N06AB03

ATC

fluoxetine; oral

2.2

54.7

501

2418

N05AA01

ATC

chlorpromazine; systemic, rectal

5.8

53.9

174

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

53.7

287

1079

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

12.5

53.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

10.3

52.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

52.7

421

1917

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

52.7

198

607

N06AA09

ATC

amitriptyline; systemic

2.3

52.3

445

2082

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.5

52.0

101

187

N05BA12

ATC

alprazolam; oral

2.3

51.5

438

2048

P16

ICPC

Acute alcohol abuse

5.1

51.1

108

216

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

51.0

184

550

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.5

50.3

128

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.3

50.0

101

194

N06AA12

ATC

doxepin; systemic

2.8

49.9

264

986

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

49.8

1226

8206

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.8

49.8

114

244

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.8

49.7

271

1028

P72

ICPC

Schizophrenia

4.6

49.5

119

265

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.8

49.3

255

941

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.0

49.0

140

356

SPAT1263

SPAT

Sampling

1.7

48.9

1595

11489

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

15.7

48.6

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.7

48.6

163

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

48.2

373

1673

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

48.2

705

4030

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.1

47.8

138

Z72.2

ICD-10 Finland

Drug use

11.2

47.6

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.9

47.4

144

383

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

+∞

47.0

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

12.6

47.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.8

46.9

246

914

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

46.8

328

1407

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.0

46.6

103

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

12.2

46.2

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

7.0

46.2

101

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.3

45.9

175

541

N06AX03

ATC

mianserin; oral

2.8

45.8

240

891

P29

ICPC

Psychological sympt/compl other

2.6

45.8

276

1101

Y94.0

ICD-10 Finland

Accident at home

4.1

45.6

126

313

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.3

45.3

122

N06AB10

ATC

escitalopram; oral

1.9

45.0

713

4173

N18

ICPC

Paralysis/weakness

3.8

44.8

139

375

N03AX14

ATC

levetiracetam; systemic

3.4

44.7

162

485

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.9

44.6

224

813

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.9

44.6

222

802

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

44.1

362

1663

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.0

44.0

128

330

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

43.9

229

848

SPAT1240

SPAT

Therapeutic discussion

2.3

43.8

362

1669

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.7

42.9

103

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.3

42.8

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.3

42.8

168

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

42.8

320

1412

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.9

42.8

206

731

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.6

42.7

101

222

Z3226

NOMESCO Finland

Physiotherapist

1.8

42.7

738

4431

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

42.5

164

511

V03AA01, ,

ATC

4.4

41.6

104

239

TAB00

NOMESCO Finland

Lumbar puncture

2.9

41.6

204

731

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

41.1

287

1227

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.0

40.7

122

N02BE01

ATC

paracetamol; systemic, rectal

2.0

40.7

3384

30288

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

8.2

40.6

R5110, ,

SPAT

2.1

40.5

414

2075

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

6.4

40.5

106

C07AB07

ATC

bisoprolol; oral

1.6

40.5

2052

16180

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.2

40.4

113

F61.0

ICD-10 Finland

Mixed personality disorders

5.3

40.0

156

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

39.7

743

4558

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

39.6

406

2037

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.4

39.6

150

N05AF05

ATC

zuclopenthixol; systemic

6.2

39.6

112

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

7.0

39.4

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.0

39.3

116

N03AF01

ATC

carbamazepine; oral, rectal

2.5

39.1

249

1019

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.5

38.7

N06AX26

ATC

vortioxetine; oral

2.4

38.7

284

1242

L99

ICPC

Musculoskeletal disease other

3.6

38.6

130

371

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.8

38.6

117

311

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

38.5

407

2066

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

38.2

157

508

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

10.9

38.2

C07AA05

ATC

propranolol; systemic

1.8

38.2

694

4216

E87.2

ICD-10 Finland

Acidosis

7.3

38.1

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

37.9

547

3094

SPAT1125

SPAT

Stoma care and guidance

3.8

37.9

117

315

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

85.0

37.8

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.7

37.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

37.6

227

905

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

37.6

325

1523

3599X

ICD-9 Finland

Muscular dystrophies and other myopathies, Myopathy, unspecified

+∞

37.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

37.4

338

1613

N02AX02

ATC

tramadol; systemic, rectal

1.6

37.2

1668

12706

A29

ICPC

General symptom/complaint other

1.8

37.0

593

3465

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

9.1

36.9

R33

ICD-10 Finland

Retention of urine

2.0

36.8

429

2255

R50.9

ICD-10 Finland

Fever, unspecified

1.8

36.5

630

3764

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

36.3

338

1632

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.6

36.2

211

827

SPAT1265

SPAT

Breathalyser

5.9

36.1

112

E0000UV, ,

ATC

1.6

36.0

1512

11327

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

11.0

35.5

G71.8

ICD-10 Finland

Other primary disorders of muscles

+∞

35.5

R55

ICD-10 Finland

Syncope and collapse

1.9

35.4

517

2931

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

35.3

679

4183

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.5

35.3

125

369

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

35.1

894

5941

ZY000

NOMESCO Finland

Hospital inpatient

5.0

35.0

152

A02BC02

ATC

pantoprazole; systemic

1.6

34.7

2575

21745

K08.3

ICD-10 Finland

Retained dental root

2.1

34.6

360

1814

F31

ICD-10 Finland

Bipolar affective disorder

5.6

34.5

117

WX730

NOMESCO Finland

Conventional respirator

4.1

34.5

244

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

8.5

34.4

N05CF02

ATC

zolpidem; oral

1.8

34.2

632

3846

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.5

34.2

120

352

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

34.2

532

3075

ZZA00

NOMESCO Finland

Split skin graft

3.0

34.0

158

549

L19

ICPC

Muscle symptom/complaint NOS

3.1

34.0

142

464

G71.18

ICD-10 Finland

Other myotonic disease

93.4

33.8

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

11.4

33.6

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

10.4

33.3

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

12.3

33.3

J01FF01

ATC

clindamycin; systemic

1.6

33.0

1010

7007

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

32.9

680

4267

N05AL01

ATC

sulpiride; systemic

4.4

32.8

193

IGV01

NOMESCO Finland

Psychiatric network contact

5.9

32.6

N03AF02

ATC

oxcarbazepine; oral

2.9

32.4

153

537

M62.5

ICD-10 Finland

Muscle wasting and atrophy, not elsewhere classified

13.0

32.3

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

32.3

736

4741

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

32.1

1115

7959

N30.0

ICD-10 Finland

Acute cystitis

1.7

31.9

631

3910

G72

ICD-10 Finland

Other myopathies

166.4

31.7

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

8.9

31.6

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

31.5

476

2722

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

7.9

31.5

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

31.4

275

1295

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

31.3

178

689

G72.4

ICD-10 Finland

Inflammatory myopathy, not elsewhere classified

+∞

31.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

31.2

413

2263

A08

ICPC

Swelling

2.2

31.1

274

1292

SPAT1211

SPAT

Application of soft bandage

2.0

31.1

360

1883

SPAT1252

SPAT

Overall medication plan or its review

2.1

31.0

317

1584

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

31.0

310

1536

Z08

ICPC

Social welfare problem

4.4

30.9

181

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

30.9

542

3243

X58

ICD-10 Finland

Exposure to other specified factors

1.8

30.8

550

3306

F34.1

ICD-10 Finland

Dysthymia

2.9

30.8

146

513

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

30.7

152

547

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.3

30.5

187

G70.0

ICD-10 Finland

Myasthenia gravis

+∞

30.2

AA1XD

NOMESCO Finland

Other special CT of head and brain

8.0

30.2

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

11.6

30.0

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

30.0

223

979

U04

ICPC

Incontinence urine

2.1

30.0

294

1446

A01

ICPC

Pain general/multiple sites

1.9

30.0

418

2329

L76

ICPC

Fracture: other

2.7

30.0

163

617

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

29.8

377

2033

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.1

29.7

208

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

6.8

29.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

29.6

424

2381

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.0

29.5

F20.0

ICD-10 Finland

Paranoid schizophrenia

6.5

29.4

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

29.2

278

1351

F22.0

ICD-10 Finland

Delusional disorder

4.1

29.1

198

P20

ICPC

Memory disturbance

1.7

29.1

676

4363

P19

ICPC

Drug abuse

6.0

29.0

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

29.0

393

2169

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

28.9

1057

7598

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.8

28.8

134

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

28.7

642

4101

P18

ICPC

Medication abuse

5.7

28.6

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.7

28.6

SPAT1227

SPAT

Substance abuse rehabilitation

7.6

28.4

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.8

28.4

OAB43, ,

SPAT

0.5

28.4

250

4886

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

28.3

502

3008

M03BX01

ATC

baclofen; systemic

3.5

28.2

286

SPAT1053

SPAT

Memory test

1.7

28.1

650

4188

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

28.1

123

414

X31

ICD-10 Finland

Exposure to excessive natural cold

8.8

28.0

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

27.9

201

870

R42

ICD-10 Finland

Dizziness and giddiness

1.6

27.9

909

6360

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.9

27.9

209

N05CD02

ATC

nitrazepam; oral

3.5

27.8

284

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

6.0

27.7

S18

ICPC

Laceration/cut

1.5

27.6

1765

14161

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

7.8

27.6

F03

ICD-10 Finland

Unspecified dementia

2.2

27.5

242

1140

SPAT1262

SPAT

Handing over of treatment supplies

1.6

27.5

702

4636

N87

ICPC

Parkinsonism

3.4

27.4

100

301

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

35.3

27.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

27.4

177

729

Z3231

NOMESCO Finland

Registered nurse

1.5

27.3

1019

7341

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

6.8

27.1

G71.11

ICD-10 Finland

Dystrophia myotonica [Steinert]

+∞

27.1

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

5.7

26.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

26.8

134

485

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

9.0

26.8

SPAT1139

SPAT

Nutrition survey

2.6

26.8

161

641

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

26.6

270

1345

N06AX05

ATC

trazodone; oral

3.2

26.5

108

348

N06AA06

ATC

trimipramine; systemic

3.1

26.5

113

374

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.7

26.5

226

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

7.6

26.3

T51.0

ICD-10 Finland

Toxic effect: Ethanol

8.8

26.3

WX872

NOMESCO Finland

Intensive care

2.2

26.1

239

1144

L04AX01

ATC

azathioprine; systemic

2.5

26.1

163

661

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

26.1

293

1515

R13

ICD-10 Finland

Dysphagia

2.0

26.0

305

1601

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

25.8

384

2180

G56.3

ICD-10 Finland

Lesion of radial nerve

5.2

25.7

104

P03

ICPC

Feeling depressed

2.0

25.6

287

1483

WX882

NOMESCO Finland

High dependency care

2.8

25.5

134

498

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.9

25.5

119

415

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

8.3

25.2

P28

ICPC

Limited function/disability (P)

5.0

25.1

110

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

25.0

134

504

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

24.9

231

1112

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.6

24.8

227

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.0

24.8

109

368

N02BF02

ATC

pregabalin; oral

2.0

24.7

261

1319

P76

ICPC

Depressive disorder

2.2

24.6

206

951

J01MA12

ATC

levofloxacin; systemic

1.6

24.5

730

4986

S70.0

ICD-10 Finland

Contusion of hip

2.3

24.3

190

852

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

24.3

817

5734

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.9

24.2

N05AB01

ATC

dixyrazine; systemic

4.0

24.1

172

M79.6

ICD-10 Finland

Pain in limb

1.4

23.9

1513

12016

M48.0

ICD-10 Finland

Spinal stenosis

1.7

23.8

519

3282

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

67.9

23.8

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.5

23.8

243

N03AX18

ATC

lacosamide; systemic

5.7

23.8

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

23.8

243

1213

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

23.8

197

906

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

7.2

23.7

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.4

23.5

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

23.5

115

412

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.3

23.5

185

833

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

23.4

347

1965

J01DB01

ATC

cefalexin; oral

1.5

23.4

2980

26775

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

7.1

23.3

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.9

23.3

172

R40.2

ICD-10 Finland

Coma, unspecified

4.3

23.2

138

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.1

23.2

155

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.5

23.1

147

601

SPAT1251

SPAT

Organisation of medication

2.4

23.1

167

724

S22.3

ICD-10 Finland

Fracture of rib

1.9

23.1

319

1767

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.2

23.1

147

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

23.0

332

1864

R4120

NOMESCO Finland

Occupational therapy

2.0

23.0

260

1347

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

6.7

22.9

TK810

NOMESCO Finland

Hemofiltration

5.7

22.9

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

22.8

467

2904

SPAT1243

SPAT

Psychiatric/psychological examination

3.3

22.8

255

JN4AD

NOMESCO Finland

Body CT examination

1.7

22.7

467

2906

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.0

22.7

100

338

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

22.6

900

6529

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

22.5

166

727

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

22.5

132

520

ZY010

NOMESCO Finland

Hospital outpatient

2.3

22.4

176

792

A41.8

ICD-10 Finland

Other specified sepsis

2.9

22.3

106

374

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.8

22.3

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.8

22.3

113

413

M79.1

ICD-10 Finland

Myalgia

1.7

22.1

489

3101

S00.0

ICD-10 Finland

Superficial injury of scalp

2.7

22.1

122

466

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

22.0

489

3106

F20

ICD-10 Finland

Schizophrenia

5.5

21.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

21.9

122

468

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

21.9

124

480

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

21.7

1377

10890

N06AA10

ATC

nortriptyline; systemic

3.1

21.7

294

N05AE04

ATC

ziprasidone; systemic

7.7

21.7

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

21.6

505

3246

XA402

NOMESCO Finland

ENMG

2.9

21.6

102

359

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.7

21.4

187

Z31.5

ICD-10 Finland

Genetic counselling

2.4

21.4

153

660

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.8

21.4

105

377

R52.2

ICD-10 Finland

Other chronic pain

2.4

21.4

153

661

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

21.4

349

2035

RS221, ,

NOMESCO Finland

3.7

21.3

183

G20

ICD-10 Finland

Parkinson disease

2.3

21.3

159

699

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

21.3

413

2528

N06AB05

ATC

paroxetine; oral

2.2

21.3

194

927

SPAT1260

SPAT

Consultation of another employee

1.6

21.2

623

4228

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

21.2

128

511

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.5

21.1

139

578

S01.9

ICD-10 Finland

Open wound of head, part unspecified

3.1

21.0

294

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

21.0

243

1269

N06AX12

ATC

bupropion; oral

2.1

20.9

202

988

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

20.7

362

2152

N02BF01

ATC

gabapentin; oral

1.7

20.7

371

2221

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

20.7

280

1540

N06AG02

ATC

moclobemide; oral

2.3

20.6

159

710

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

15.8

20.5

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

20.5

325

ZYY01

NOMESCO Finland

Contact between professionals

6.7

20.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

20.3

214

1081

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.3

20.2

123

P01

ICPC

Feeling anxious/nervous/tense

1.8

20.1

308

1761

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

20.1

293

1650

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

20.1

470

3020

R5130, ,

SPAT

6.4

20.1

H02AB06

ATC

prednisolone; systemic

1.4

20.1

1698

14033

L29

ICPC

Musculoskeletal sympt/complt other

1.8

20.0

331

1937

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

20.0

928

6915

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.9

20.0

330

R27.0

ICD-10 Finland

Ataxia, unspecified

6.0

19.9

G71.00

ICD-10 Finland

Muscular dystrophy benign [Becker]

+∞

19.8

SPAT1360

SPAT

Extensive global examination

1.9

19.8

267

1468

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.3

19.7

144

628

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

19.6

112

435

C03DA01

ATC

spironolactone; oral

1.6

19.6

512

3378

SPAT1304

SPAT

Counselling and guidance related to ageing

1.8

19.6

331

1948

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.6

19.6

116

459

R4110

NOMESCO Finland

Physiotherapy

1.4

19.6

984

7437

K07

ICPC

Swollen ankles/oedema

2.0

19.4

223

1161

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

19.4

284

1602

R06.0

ICD-10 Finland

Dyspnoea

1.4

19.4

1027

7835

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

19.3

347

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

19.3

163

M54.5

ICD-10 Finland

Low back pain

1.4

19.3

1213

9530

D21

ICPC

Swallowing problem

3.1

19.2

267

G04BD12

ATC

mirabegron; oral

1.6

19.2

475

3093

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

19.2

160

738

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

7.9

19.1

N05BA09

ATC

clobazam; oral

6.0

19.0

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.4

19.0

208

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.3

19.0

213

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

18.9

279

1577

N05CD08

ATC

midazolam; nasal, systemic

2.6

18.9

108

420

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.4

18.8

130

553

29999

ICD-8 Finland

Unspecified psychosis

6.4

18.8

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

5.1

18.8

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.4

18.8

132

566

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

18.7

1448

11754

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

6.6

18.7

L75

ICPC

Fracture: femur

3.1

18.7

261

Z03

ICPC

Housing/neighbourhood problem

4.4

18.7

105

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

20.9

18.6

W06

ICD-10 Finland

Fall involving bed

3.8

18.6

149

S72.0

ICD-10 Finland

Fracture of neck of femur

2.0

18.5

204

1046

UJF32

NOMESCO Finland

Coloscopy

1.4

18.5

950

7194

J01MA02

ATC

ciprofloxacin; systemic

1.4

18.5

1438

11676

G40

ICD-10 Finland

Epilepsy

4.3

18.5

110

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

18.5

978

7448

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

18.4

127

540

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

18.4

409

2592

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

18.4

938

7095

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

18.4

195

987

EBA00

NOMESCO Finland

Extraction of tooth

1.4

18.3

1220

9659

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

6.6

18.3

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.3

18.2

140

624

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.3

18.2

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

18.2

1230

9760

A02BC01

ATC

omeprazole; systemic

1.4

18.2

964

7340

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

18.1

309

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.3

18.0

108

R52.1

ICD-10 Finland

Chronic intractable pain

4.1

18.0

121

OAA67, ,

SPAT

0.4

17.9

120

2612

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

17.8

103

403

OAA80, ,

SPAT

0.3

17.8

1555

G12.2

ICD-10 Finland

Motor neuron disease

4.7

17.7

108

Kela drug reimbursment

Myasthenia gravis

+∞

17.7

G72.1

ICD-10 Finland

Alcoholic myopathy

+∞

17.7

G71.0

ICD-10 Finland

Muscular dystrophy

+∞

17.7

A07AA09

ATC

vancomycin; oral

3.1

17.7

233

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

17.7

125

538

N03AB02

ATC

phenytoin; systemic

3.5

17.5

174

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

17.5

571

3953

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

3.4

17.5

189

R4120, ,

SPAT

3.3

17.5

204

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

17.5

467

3094

L17

ICPC

Foot/toe symptom/complaint

1.4

17.4

1050

8165

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

17.3

2385

21042

AA400

NOMESCO Finland

Electroconvulsive therapy

4.7

17.3

C08CA01

ATC

amlodipine; oral

1.4

17.3

1502

12374

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

13.9

17.2

R51.80

ICD-10 Finland

Headache

1.6

17.2

474

3160

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

17.2

205

1082

H02AB09

ATC

hydrocortisone; systemic

2.6

17.1

376

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

17.1

171

848

SPAT1127

SPAT

Enema

3.9

17.1

126

NC2AA

NOMESCO Finland

Forearm X-ray examination

3.1

17.0

223

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

17.0

127

560

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

5.6

16.9

RS220, ,

NOMESCO Finland

3.5

16.9

164

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

16.9

374

2367

NA2AD

NOMESCO Finland

Thoracic spine CT examination

4.4

16.8

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

16.8

283

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

16.8

103

415

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.5

16.8

160

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

16.8

1279

10315

F20.10

ICD-10 Finland

Raise schizophrenia continuously

6.3

16.7

S43.0

ICD-10 Finland

Dislocation of shoulder joint

2.2

16.7

149

707

G71.28

ICD-10 Finland

Other congenital myopathy

+∞

16.7

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.3

16.6

R11

ICD-10 Finland

Nausea and vomiting

1.7

16.6

318

1938

N05AD03

ATC

melperone; systemic

3.2

16.5

206

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.4

16.5

181

K92.0

ICD-10 Finland

Haematemesis

2.4

16.5

111

467

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

16.5

208

1118

SPAT1310

SPAT

Counselling related to known health issue

1.4

16.5

1053

8252

F20.5

ICD-10 Finland

Residual schizophrenia

5.1

16.5

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

5.1

16.5

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

16.4

171

860

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.4

16.4

177

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

16.4

891

6797

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

16.3

361

2283

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

16.3

357

2253

F05.8

ICD-10 Finland

Other delirium

3.6

16.3

149

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

16.2

463

3113

RS222, ,

NOMESCO Finland

3.5

16.2

164

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

16.2

449

2999

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

16.1

273

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

6.8

16.1

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

16.1

130

592

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

16.1

184

R25.2

ICD-10 Finland

Cramp and spasm

2.5

16.1

388

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.9

16.1

118

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

5.3

16.1

C09AA05

ATC

ramipril; oral

1.4

16.1

986

7671

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

16.0

149

718

N03AX11

ATC

topiramate; oral

2.9

16.0

258

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.2

16.0

195

UKC02

NOMESCO Finland

Cystoscopy

1.5

16.0

649

4692

M33.1

ICD-10 Finland

Other dermatomyositis

21.0

16.0

WYA20

NOMESCO Finland

Home visit

2.5

15.9

100

408

EBA30

NOMESCO Finland

Extraction of root of tooth

1.8

15.8

236

1339

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.8

15.7

277

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.0

15.7

223

G71.02

ICD-10 Finland

Muscular dystrophy facioscapulohumeral

+∞

15.6

G70.9

ICD-10 Finland

Myoneural disorder, unspecified

+∞

15.6

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

15.6

125

568

G12.8

ICD-10 Finland

Other spinal muscular atrophies and related syndromes

26.4

15.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

15.6

473

3222

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.7

15.4

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

6.4

15.4

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

4.1

15.3

100

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

15.3

107

459

S06.3

ICD-10 Finland

Focal brain injury

3.1

15.3

211

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

7.0

15.3

G24.9

ICD-10 Finland

Dystonia, unspecified

7.0

15.3

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

15.2

254

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.1

15.1

139

667

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.0

15.1

228

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

6.1

15.1

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.9

15.1

250

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

15.0

150

744

R4130

NOMESCO Finland

Speech therapy

2.3

14.9

107

464

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

14.8

2381

21224

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

14.8

416

2784

NBH10

NOMESCO Finland

Reduction of dislocation of humeroscapular joint, closed

4.3

14.8

N04BC05

ATC

pramipexole; oral

1.7

14.8

278

1685

29530

ICD-8 Finland

Schizophrenia, Paranoid type

5.9

14.8

X57

ICD-10 Finland

Unspecified privation

2.5

14.8

380

L84

ICD-10 Finland

Corns and callosities

2.1

14.8

133

634

R4110, ,

SPAT

1.5

14.7

451

3077

N06AX22

ATC

agomelatine; oral

2.8

14.7

265

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

6.1

14.7

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

14.6

217

1229

A99

ICPC

Disease/condition unspecnature/site

1.6

14.6

380

2498

G71.25

ICD-10 Finland

Congenital muscular dystrophy NOS

+∞

14.6

H25.8

ICD-10 Finland

Other senile cataract

1.5

14.6

467

3215

X78

ICD-10 Finland

Intentional self-harm by sharp object

5.4

14.5

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.8

14.5

256

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

14.4

926

7237

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.7

14.4

279

ZXE00

NOMESCO Finland

One hour or less

1.3

14.4

1255

10270

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.3

14.3

167

E000001, ,

ATC

1.4

14.3

619

4522

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

14.2

1151

9314

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.4

14.2

153

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

14.1

229

1331

D12

ICPC

Constipation

2.0

14.1

156

802

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.4

14.1

144

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.7

14.1

271

E87.5

ICD-10 Finland

Hyperkalaemia

2.4

14.1

395

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

14.0

178

959

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

14.0

146

735

K90

ICPC

Stroke/cerebrovascular accident

2.1

14.0

136

667

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

10.9

14.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

14.0

117

542

H03AA01

ATC

levothyroxine sodium; systemic

1.4

13.9

711

5347

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

13.9

288

1791

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

13.8

123

584

Z00.0

ICD-10 Finland

General medical examination

1.4

13.8

656

4873

Z2221

NOMESCO Finland

Medical doctor

1.4

13.7

872

6796

A10BH05

ATC

linagliptin; oral

1.8

13.7

215

1238

H02AB07

ATC

prednisone; oral

1.5

13.7

463

3221

K59.0

ICD-10 Finland

Constipation

1.8

13.7

213

1224

IGY02, ,

SPAT

3.2

13.7

162

ZXY49

NOMESCO Finland

Other health care provider

5.7

13.7

Z28

ICPC

Limited function/disability (Z)

4.2

13.7

P74

ICPC

Anxiety disorder/anxiety state

2.1

13.6

123

588

N88

ICPC

Epilepsy

4.3

13.6

30188

ICD-8 Finland

Personality disorders, Alia definita

4.7

13.5

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.6

13.5

124

SPAT1281

SPAT

Other administrative function

1.7

13.5

261

1594

H53.2

ICD-10 Finland

Diplopia

2.1

13.5

125

603

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.7

13.4

278

S14.3

ICD-10 Finland

Injury of brachial plexus

6.1

13.4

P73

ICPC

Affective psychosis

6.1

13.4

NFM10

NOMESCO Finland

Fasciotomy of thigh

12.8

13.4

R52.9

ICD-10 Finland

Pain, unspecified

1.6

13.3

342

2240

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

13.3

368

Z29

ICPC

Social problem NOS

2.4

13.3

362

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

13.3

146

749

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

13.2

305

1948

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

10.5

13.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.1

13.2

181

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.5

13.2

310

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.5

13.2

131

IHZ05, ,

SPAT

2.3

13.1

101

452

G04BD08

ATC

solifenacin; oral

1.7

13.1

252

1536

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.6

13.1

276

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

13.1

201

1151

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

13.0

441

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

11.0

13.0

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

13.0

12.9

R26.0

ICD-10 Finland

Ataxic gait

5.6

12.9

OAB48, ,

SPAT

0.5

12.9

130

2460

S09.9

ICD-10 Finland

Unspecified injury of head

2.7

12.9

261

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.7

12.9

261

K92.1

ICD-10 Finland

Melaena

1.7

12.9

220

1299

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.9

1463

12366

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

12.8

111

521

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.3

12.8

393

29599

ICD-8 Finland

Schizophrenia, Unspecified type

4.9

12.8

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

12.8

314

Y96.9

ICD-10 Finland

Unspecified type of accident

2.5

12.8

314

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

12.8

326

Z43.5

ICD-10 Finland

Attention to cystostomy

3.7

12.8

105

ZXD35

NOMESCO Finland

Usual procedure

2.1

12.8

119

575

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

11.6

12.8

T90

ICPC

Diabetes non-insulin dependent

1.3

12.8

896

7080

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.7

12.7

110

NH1AD

NOMESCO Finland

Ankle and foot CT

2.4

12.7

340

K85

ICD-10 Finland

Acute pancreatitis

2.6

12.7

269

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.3

12.6

396

RD210, ,

NOMESCO Finland

2.8

12.6

224

RS121, ,

NOMESCO Finland

4.4

12.6

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.4

12.6

B01AB05

ATC

enoxaparin; parenteral

1.3

12.6

1074

8726

IFC04, ,

SPAT

15.5

12.6

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.5

12.6

M79.7

ICD-10 Finland

Fibromyalgia

2.3

12.5

423

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.5

12.5

312

G71.12

ICD-10 Finland

Myotonia congenita

+∞

12.5

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

12.5

127

635

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.3

12.5

386

D07AC01

ATC

betamethasone; topical

1.3

12.5

1211

10015

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

9.3

12.5

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

24.4

12.4

183

Kela drug reimbursment

Lamotrigin and topiramate

4.0

12.4

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

12.4

541

3949

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

12.4

186

1057

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

5.6

12.4

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

12.4

121

596

E000003, ,

ATC

2.0

12.4

137

706

SPAT1138

SPAT

Guidance concerning bowel function

2.7

12.4

255

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

12.3

120

590

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

12.3

251

1554

SPAT1104

SPAT

Monitoring of emergency patient

1.7

12.3

229

1384

J01EA01

ATC

trimethoprim; systemic

1.4

12.3

813

6360

K56.0

ICD-10 Finland

Paralytic ileus

3.3

12.3

142

5CM18, ,

NOMESCO Finland

5.4

12.3

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

10.5

12.2

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.4

12.2

128

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

4.5

12.1

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

12.1

127

642

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

12.1

571

4227

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

12.1

1190

9848

Z72.0

ICD-10 Finland

Tobacco use

2.3

12.1

385

F32.8

ICD-10 Finland

Other depressive episodes

2.8

12.0

202

E66.8

ICD-10 Finland

Other obesity

1.9

12.0

144

762

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

18.1

12.0

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.6

12.0

259

A10BA02

ATC

metformin; oral

1.3

12.0

1049

8545

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

5.7

11.9

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

13.4

11.9

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

11.9

218

1312

NF3AA

NOMESCO Finland

Femur X-ray examination

2.2

11.9

445

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

11.9

410

2863

J01CF05

ATC

flucloxacillin; systemic

1.7

11.9

238

1468

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

5.4

11.8

S76

ICPC

Skin infection other

1.8

11.8

194

1133

A02BC05

ATC

esomeprazole; systemic

1.3

11.8

1330

11195

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

11.7

11.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

11.8

167

933

M54.1

ICD-10 Finland

Radiculopathy

2.0

11.8

135

704

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

4.2

11.8

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.7

11.8

102

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.3

11.7

136

G93.4

ICD-10 Finland

Encephalopathy, unspecified

8.9

11.7

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.3

11.7

Z2445

NOMESCO Finland

Psychologist

2.1

11.7

110

534

M05BA04

ATC

alendronic acid; oral

1.5

11.7

326

2175

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

11.7

304

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

11.6

121

610

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

11.6

1001

8129

NJ3CM

NOMESCO Finland

Extensive MRI examination of extremities with 3 Tesla magnet

65.1

11.6

B01AA03

ATC

warfarin; systemic

1.3

11.6

784

6149

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.8

11.5

163

911

X84

ICD-10 Finland

Intentional self-harm by unspecified means

8.6

11.5

N05AF01

ATC

flupentixol; systemic

2.7

11.5

230

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

11.5

185

1075

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

11.5

381

2639

G72.2

ICD-10 Finland

Myopathy due to other toxic agents

+∞

11.5

NK1AK

NOMESCO Finland

Spectroscopy of muscles

+∞

11.5

SPAT1247

SPAT

Outpatient detoxication and monitoring

5.0

11.5

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

11.5

219

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

11.4

103

492

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.9

11.4

175

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.4

11.4

326

F21

ICD-10 Finland

Schizotypal disorder

4.7

11.4

SPAT1101

SPAT

Orthostatic test

1.8

11.4

181

1048

N19

ICD-10 Finland

Unspecified kidney failure

1.8

11.3

160

894

SPAT1153

SPAT

Removal of sutures

1.3

11.3

1063

8730

RF120, ,

NOMESCO Finland

3.1

11.3

155

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

15.1

11.3

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

8.3

11.3

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

11.3

462

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

11.3

328

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.1

11.3

111

549

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

9.6

11.2

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.2

11.2

392

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

4.7

11.2

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

5.6

11.2

R03BB04

ATC

tiotropium bromide; inhalant

1.5

11.2

382

2662

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

11.2

168

957

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

11.1

134

711

N06AB08

ATC

fluvoxamine; oral

2.2

11.1

406

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

11.1

252

S51.0

ICD-10 Finland

Open wound of elbow

2.6

11.0

229

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

11.0

618

4703

SPAT1255

SPAT

Intravenous administration of medicine

1.6

11.0

241

1519

J01DA01

ATC

[U] cefalexin

1.3

11.0

2056

18338

A10AB05

ATC

insulin aspart; parenteral

1.6

11.0

276

1798

IAA01, ,

SPAT

4.3

11.0

P98

ICPC

Psychosis NOS/other

4.4

11.0

C10AC01

ATC

colestyramine; oral

2.2

10.9

402

L73

ICPC

Fracture: tibia/fibula

2.8

10.9

185

E83.51

ICD-10 Finland

Hypocalcemia

3.7

10.9

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

10.9

391

2748

Y94.8

ICD-10 Finland

Other leisure activity accident

2.1

10.9

475

F06.7

ICD-10 Finland

Mild cognitive disorder

1.9

10.9

128

674

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

5.4

10.9

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

3.0

10.9

164

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.8

10.8

186

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.7

10.8

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

10.8

291

1926

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

10.8

353

F32

ICD-10 Finland

Depressive episode

1.9

10.8

139

754

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.2

10.8

437

R06.4

ICD-10 Finland

Hyperventilation

2.8

10.8

192

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.1

10.8

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

10.7

438

F25

ICD-10 Finland

Schizoaffective disorders

9.6

10.7

Z50.1

ICD-10 Finland

Other physical therapy

1.7

10.7

183

1082

M60.0

ICD-10 Finland

Infective myositis

21.5

10.7

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

10.7

475

3477

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.6

10.6

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

10.6

191

1145

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.1

10.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

10.6

856

6880

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.2

10.5

130

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

10.5

400

2844

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

10.5

204

1248

F60.8

ICD-10 Finland

Other specific personality disorders

4.4

10.5

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

9.2

10.5

G82.2

ICD-10 Finland

Paraplegia, unspecified

4.5

10.5

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

10.4

699

5465

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

10.4

136

741

G71.03

ICD-10 Finland

Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker

+∞

10.4

SPAT1312

SPAT

General health counselling

1.3

10.4

963

7878

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.4

10.4

111

Z10.0

ICD-10 Finland

Occupational health examination

0.4

10.4

1384

XKC03

NOMESCO Finland

Water cystometry

2.0

10.3

104

519

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

10.3

292

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

10.3

119

624

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.8

10.3

175

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

10.6

10.3

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

8.8

10.3

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

8.8

10.3

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

4.9

10.3

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

10.2

222

1397

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

9.6

10.2

F13.09

ICD-10 Finland

Intoxication caused by sedative and hypnotic UNS

23.4

10.2

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

23.4

10.2

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.7

10.2

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

10.2

205

1265

Y34

ICD-10 Finland

Unspecified event, undetermined intent

4.0

10.2

S20.2

ICD-10 Finland

Contusion of thorax

1.7

10.2

185

1113

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

13.1

10.1

XA400

NOMESCO Finland

EEG

4.1

10.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

10.1

300

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.7

10.1

199

L03

ICPC

Low back symptom/complaint

1.3

10.1

889

7223

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

10.1

251

1634

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.8

10.0

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.0

10.0

150

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

10.0

640

4967

W17

ICD-10 Finland

Other fall from one level to another

1.8

10.0

141

788

XG466

NOMESCO Finland

Sleep oxymetry

2.0

10.0

109

560

R5140, ,

SPAT

2.6

9.9

213

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.4

9.9

279

J96.0

ICD-10 Finland

Acute respiratory failure

2.5

9.8

231

F21, ,

ICPC

2.8

9.8

168

NCM10

NOMESCO Finland

Fasciotomy of forearm

12.2

9.8

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.8

9.8

148

844

P05

ICPC

Senility, feeling/behaving old

3.6

9.8

L04AA06

ATC

mycophenolic acid; systemic

2.4

9.8

274

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.5

9.8

N05AX13

ATC

paliperidone; systemic

4.7

9.8

SPAT1244

SPAT

Occupational therapy

2.9

9.8

147

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.8

9.7

169

K02.1

ICD-10 Finland

Caries of dentine

1.2

9.7

1809

16043

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

5.3

9.6

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.1

9.6

127

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

9.6

252

U05

ICPC

Urination problems other

1.6

9.6

201

1255

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.6

9.6

205

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

8.4

9.5

R02

ICPC

Shortness of breath/dyspnoea

1.4

9.5

460

3414

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.1

9.5

128

C07AB02

ATC

metoprolol; systemic

1.3

9.5

739

5897

N07BA03

ATC

varenicline; oral

1.8

9.5

133

743

IHZ04, ,

SPAT

2.7

9.4

189

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.7

9.4

174

1051

S32.4

ICD-10 Finland

Fracture of acetabulum

3.3

9.4

108

H02AB04

ATC

methylprednisolone; systemic

1.4

9.4

443

3272

E71.3

ICD-10 Finland

Disorders of fatty-acid metabolism

100.3

9.4

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.8

9.4

140

796

M72.9

ICD-10 Finland

Fibroblastic disorder, unspecified

30.1

9.4

G70.8

ICD-10 Finland

Other specified myoneural disorders

+∞

9.4

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

1.9

9.3

115

616

A10AE04

ATC

insulin glargine; parenteral

1.5

9.3

340

2397

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

21.7

9.3

A02BC03

ATC

lansoprazole; oral

1.3

9.3

941

7765

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

8.0

9.3

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

4.4

9.3

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.3

9.3

104

N05AC01

ATC

periciazine; systemic

4.7

9.3

F40.1

ICD-10 Finland

Social phobias

2.4

9.3

256

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

8.7

9.3

Z51.5

ICD-10 Finland

Palliative care

1.5

9.3

346

2452

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

9.2

217

1393

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

9.2

233

1521

B01AF02

ATC

apixaban; oral

1.4

9.2

517

3931

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

9.2

148

861

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

9.2

198

1245

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

3.2

9.2

110

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

9.2

671

5307

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

9.2

379

G04CA02

ATC

tamsulosin; oral

1.3

9.1

959

7950

G04BD11

ATC

fesoterodine; oral

2.0

9.1

102

529

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.1

9.1

406

N04BX02

ATC

entacapone; oral

4.3

9.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

9.1

226

1470

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.6

9.1

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

5.0

9.1

WX213

NOMESCO Finland

Lower leg blockade

3.1

9.1

121

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.6

9.1

193

P27

ICPC

Fear of mental disorder

2.8

9.1

159

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

4.8

9.1

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

4.6

9.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

9.0

124

688

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.4

9.0

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.5

9.0

223

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

9.0

504

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

9.0

1269

10887

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.9

9.0

116

632

RS230, ,

NOMESCO Finland

3.8

8.9

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

8.9

103

540

R35

ICD-10 Finland

Polyuria

1.5

8.9

251

1680

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

24.1

8.9

WX722

NOMESCO Finland

PEEP

1.7

8.9

161

968

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.5

8.9

213

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

4.3

8.9

Z02.4

ICD-10 Finland

Examination for driving licence

0.8

8.9

717

8822

H02AA02

ATC

fludrocortisone; oral

2.9

8.8

139

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

8.0

8.8

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

8.0

8.8

R4190

NOMESCO Finland

Nutritional therapy

1.9

8.8

115

628

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

3.6

8.8

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

8.8

352

J01CA08

ATC

pivmecillinam; oral

1.3

8.8

1080

9116

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

9.5

8.8

Z50.5

ICD-10 Finland

Speech therapy

2.7

8.8

162

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

8.8

533

4102

Z04

ICD-10 Finland

Examination and observation for other reasons

2.4

8.7

227

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

8.7

131

748

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.7

8.7

174

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

2.8

8.7

146

I50.0

ICD-10 Finland

Congestive heart failure

1.5

8.7

318

2245

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

8.7

1632

14423

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.2

8.6

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1311

1312

14.63

307.65

3.2

2.1

2147.71

312.99

ug/l

14.09

1250

1246

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2797

11057

6.58

307.65

5.6

2.2

1834.56

178.27

u/l

44.36

2699

10441

(3023368) Bacteria identified in Blood by Culture

2118

10751

3.15

264.91

5.6

4.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

226

162

14.76

248.94

2.0

1.4

9.42

6.80

u/l

0.96

194

139

(3023183) Ammonium ion [Moles/volume] in Plasma

436

809

5.95

227.49

3.1

2.7

31.22

35.76

umol/l

2.11

389

722

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1225

4970

3.15

218.84

6.2

6.1

1.06

1.04

mmol/l

1.31

1134

4628

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1339

6084

2.84

190.59

3.8

3.4

0.80

0.82

mmol/l

3.05

1235

5707

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1397

6529

2.79

187.87

2.4

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2736

17936

2.81

183.47

11.0

7.6

1.20

1.21

mmol/l

6.49

2379

15482

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2524

16064

2.66

176.54

10.4

6.9

1.20

1.21

mmol/l

12.20

2373

14825

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

741

2525

3.40

173.07

5.0

3.8

5.24

5.15

kpa

1.52

705

2411

(3009343) pH of Capillary blood

721

2451

3.39

168.74

5.0

3.9

7.41

7.42

1.98

624

2024

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

650

2143

3.45

159.13

4.8

3.7

1.80

1.92

mmol/l

0.31

506

1559

(3024561) Albumin [Mass/volume] in Serum or Plasma

2453

15904

2.49

156.60

5.8

5.2

33.08

35.10

g/l

43.26

2251

14873

(3019309) Folate [Moles/volume] in Red Blood Cells

1294

6651

2.42

134.30

2.1

1.8

1202.24

1157.93

nmol/l

0.82

952

5025

(3013826) Glucose [Moles/volume] in Serum or Plasma

2814

20418

2.40

124.65

8.6

5.3

6.89

6.84

mmol/l

0.34

2745

19479

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2593

18175

2.30

124.60

7.2

6.7

11.65

12.32

umol/l

1.44

2450

17336

(3031040) Bacteria [#/volume] in Urine by Automated count

2942

21840

2.47

122.53

6.9

5.1

849.38

2108.86

e6/l

0.97

352

(3020779) Urea [Moles/volume] in Serum or Plasma

833

3636

2.65

120.87

7.8

7.2

12.26

10.61

mmol/l

5.57

790

3476

(3032080) INR in Blood by Coagulation assay

2469

17137

2.23

118.86

19.0

17.9

1.29

1.33

inr

3.03

2150

14420

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

251

7.30

117.59

2.0

1.4

1.31

1.17

promille

0.46

151

196

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1785

10962

2.17

116.86

3.4

2.7

61.66

67.78

u/l

0.37

1648

10145

(3009466) Valproate [Moles/volume] in Serum or Plasma

243

486

5.27

115.35

5.9

5.1

347.48

343.55

umol/l

0.15

214

433

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2092

13744

2.14

114.02

6.4

4.2

70.01

96.12

ng/l

0.38

1837

10414

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

425

1322

3.49

112.18

5.7

4.1

24.75

24.84

mmol/l

0.21

388

1213

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

996

4910

2.39

110.16

2.1

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1614

9694

2.14

110.09

2.7

2.4

3.10

2.90

mg/l

2.52

1351

8350

(3022313) Gas panel - Capillary blood

495

1720

3.15

109.00

5.5

4.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

870

4061

2.48

108.44

5.8

3.7

5.88

5.83

kpa

0.58

837

3957

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

773

3461

2.54

105.01

2.5

1.8

1.79

1.54

11.03

644

3001

(3014111) Lactate [Moles/volume] in Serum or Plasma

775

3506

2.52

102.80

9.5

7.6

1.54

1.36

mmol/l

3.46

761

3433

(3012544) pH of Venous blood

859

4100

2.41

101.16

5.9

3.7

7.37

7.38

0.99

561

2430

(3002032) Base excess in Venous blood by calculation

834

3942

2.42

100.29

5.9

3.7

1.86

mmol/l

0.00

732

3422

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

135

175

7.96

97.93

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1665

10545

2.02

94.35

2.1

1.7

17.89

19.89

nmol/l

6.40

1407

8908

(42870588) Differential panel, method unspecified - Blood

1774

11578

1.99

91.40

7.4

6.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2237

15823

1.99

91.06

2.6

2.2

92.56

94.67

pmol/l

1.18

1363

8530

(3022948) Iron [Moles/volume] in Serum or Plasma

1143

6414

2.11

89.19

2.9

2.7

10.94

12.44

umol/l

10.26

1015

5971

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3162

25542

2.33

87.83

10.7

8.4

82.59

81.24

u/l

0.79

3007

24214

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

395

1362

3.12

87.39

2.2

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

450

1676

2.91

86.82

2.1

1.9

2.23

2.22

ug/l

0.01

368

1471

(3024354) Oxygen [Partial pressure] in Venous blood

721

3404

2.38

85.63

5.5

3.1

4.54

4.47

kpa

0.33

685

3313

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

411

1472

3.01

85.02

2.3

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

735

3532

2.34

83.64

2.5

2.2

0.19

0.20

g/l

6.81

658

3283

(3013115) Eosinophils [#/volume] in Blood

2373

17450

1.94

82.41

8.6

6.5

0.18

0.20

e9/l

2.87

2085

15053

(3006504) Eosinophils/Leukocytes in Blood

2185

15641

1.92

82.29

8.5

6.5

2.54

2.84

8.22

2051

14631

(3006315) Basophils [#/volume] in Blood

2322

16958

1.93

82.26

8.1

6.2

0.04

e9/l

1.89

2046

14411

(3022096) Basophils/Leukocytes in Blood

2182

15625

1.91

81.95

8.6

6.6

0.59

0.66

7.64

2048

14616

(3001604) Monocytes [#/volume] in Blood

2314

16908

1.92

81.53

8.1

6.2

0.64

0.61

e9/l

4.80

2036

14354

(3019069) Monocytes/Leukocytes in Blood

2184

15680

1.91

80.97

8.6

6.6

8.99

9.10

1.01

2050

14672

(3028707) Methadone [Presence] in Urine by Screen method

175

361

5.03

79.92

4.1

3.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

610

2756

2.44

79.48

2.0

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1760

11834

1.90

79.41

3.7

3.4

2202.28

1686.53

ng/l

2.46

1512

10323

(3019198) Lymphocytes [#/volume] in Blood

2343

17281

1.91

79.15

8.3

6.3

1.80

1.89

e9/l

0.80

2091

15037

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1064

6038

2.05

78.98

2.9

2.7

2.21

2.27

g/l

2.13

945

5571

(3007853) Bacteria identified in Skin by Aerobe culture

806

4117

2.21

78.75

2.4

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1003

5614

2.06

77.02

2.9

2.7

20.00

22.20

5.55

896

5221

(3036481) Cortisol [Moles/volume] in Serum or Plasma

650

3077

2.34

75.98

2.3

2.2

358.46

381.43

nmol/l

1.95

588

2835

(3019225) pH of Specimen

697

3400

2.28

75.92

6.2

4.5

7.37

7.36

1.98

559

2445

(3018010) Neutrophils/Leukocytes in Blood

2160

15669

1.86

75.18

8.3

6.4

60.44

58.16

13.86

2054

14945

(3002030) Lymphocytes/Leukocytes in Blood

2188

15968

1.86

74.36

8.6

6.5

24.44

26.55

14.71

2075

15106

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

109

154

7.25

73.29

15.9

16.4

9988.23

791.33

nmol/l

0.49

104

149

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2061

14859

1.83

71.87

3.0

2.4

74.18

78.06

nmol/l

6.13

1806

13264

(3019977) pH of Arterial blood

852

4596

2.10

71.58

9.7

7.7

7.41

7.42

0.63

546

2544

(3027801) Oxygen [Partial pressure] in Arterial blood

852

4596

2.10

71.58

9.7

7.7

11.10

12.08

kpa

7.66

822

4411

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

852

4597

2.10

71.54

9.7

7.7

5.18

5.09

kpa

1.29

823

4411

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

853

4605

2.09

71.51

2.2

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2486

19028

1.86

70.94

12.4

9.5

4.73

4.25

e9/l

13.02

2210

16399

(3023520) Reticulocytes [#/volume] in Blood

715

3619

2.20

70.72

2.3

2.6

68.46

68.28

e9/l

0.05

536

2648

(3027945) Reticulocytes/Erythrocytes in Blood

854

4648

2.08

69.86

2.3

2.6

1.86

1.80

0.98

706

4113

(3003396) Base excess in Arterial blood by calculation

843

4567

2.08

69.81

9.6

7.7

1.52

0.97

mmol/l

2.56

707

3735

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

518

2302

2.44

69.41

6.5

3.7

24.06

24.19

mmol/l

0.36

504

2278

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

834

4540

2.07

67.97

3.0

4.2

264.81

245.96

u/l

2.71

772

4283

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2035

14778

1.80

67.68

3.6

3.1

170.41

146.56

ug/l

2.97

1822

13674

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

463

1997

2.50

66.03

1.7

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

662

3353

2.18

64.88

2.8

2.4

14.51

7.44

ug/l

4.48

526

2943

(3000991) Gas panel - Venous blood

666

3383

2.17

64.79

11.8

8.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

330

1234

2.83

62.53

1.4

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

651

3328

2.15

62.09

2.2

2.6

64.46

66.19

g/l

5.87

568

3032

(3003181) Sodium [Moles/volume] in Urine

234

725

3.37

61.34

1.5

1.3

57.82

61.94

mmol/l

0.67

170

581

(3026782) Osmolality of Urine

1138

7114

1.85

60.63

3.8

3.1

504.15

537.62

mosm/kgh2o

6.35

1039

6247

(3016502) Oxygen saturation in Arterial blood

755

4123

2.03

60.21

10.2

8.0

94.71

95.48

2.00

728

3975

(3015377) Calcium [Moles/volume] in Serum or Plasma

1705

12036

1.75

59.98

3.3

3.5

2.33

2.35

mmol/l

10.54

1507

10880

(3018418) pH of Serum or Plasma

1564

10801

1.75

59.24

5.6

4.3

7.40

0.37

1201

7863

(1616796) Gas panel - Central venous blood

251

835

3.15

58.51

4.0

4.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

154

6.44

58.48

2.2

2.4

162.47

99.60

umol/l

0.81

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2595

20731

1.77

57.58

5.4

3.4

69.48

53.73

u/l

6.05

2413

19307

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

101

176

5.87

55.46

1.1

4.45

0.11

nmol/l

0.79

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

105

191

5.62

55.11

2.5

2.4

—

(3000850) Epithelial cells [#/volume] in Urine

1246

8217

1.76

54.34

3.5

2.8

5.60

4.94

e6/l

1.00

1179

7503

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

134

307

4.49

53.82

1.6

—

(3014271) Vancomycin [Susceptibility]

103

190

5.54

53.26

4.0

3.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

101

7.55

52.59

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

101

7.55

52.59

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

101

7.55

52.59

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

101

7.55

52.59

1.1

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

206

660

3.24

51.06

4.3

2.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1139

7455

1.75

50.21

1.8

18874610.19

22220838.25

pmol/l

0.09

906

6125

(3037522) Nuclear Ab [Titer] in Serum

731

4178

1.93

50.18

1.4

1.3

468.74

519.48

titre

0.36

167

925

(44816559) Phosphatidylethanol [Mass/volume] in Blood

322

1327

2.56

50.09

2.1

1.7

0.35

0.32

mg/l

0.41

164

639

(3027315) Oxygen [Partial pressure] in Blood

221

754

3.05

49.23

5.0

4.8

8.53

8.41

kpa

0.38

213

739

(3012501) Base excess in Blood by calculation

220

749

3.05

49.19

5.0

4.8

2.54

2.66

mmol/l

0.27

162

509

(3013290) Carbon dioxide [Partial pressure] in Blood

220

750

3.05

49.08

5.0

4.8

4.94

5.05

kpa

1.31

212

736

(3021601) Nitrite [Presence] in Urine by Test strip

2221

17404

1.65

48.76

5.0

4.1

0.00

estimate

0.50

542

3746

(3002582) Erythrocytes [#/volume] in Urine

1627

11790

1.66

48.68

4.6

3.6

50.30

79.60

e6/l

1.96

1364

9101

(3035350) Ketones [Presence] in Urine by Test strip

2236

17593

1.65

47.92

5.0

4.1

15.97

4.57

estimate

1.05

546

3834

(3011288) Drugs identified in Urine by Screen method Nominal

183

568

3.33

47.74

6.3

3.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2247

17712

1.64

47.71

5.0

4.1

0.00

0.10

estimate

0.63

530

3555

(3030467) Casts [#/volume] in Urine by Automated count

1434

10143

1.66

46.60

4.5

3.5

0.58

0.46

e6/l

0.89

1177

7559

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

107

6.84

46.22

2.4

2.2

141.03

146.95

nmol/l

0.17

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

535

2819

2.04

46.10

4.0

98.00

95.62

ng/l

0.19

442

2421

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1510

10844

1.65

46.08

4.4

3.3

51.12

38.52

u/l

3.78

1402

10209

(3016879) Cocaine [Presence] in Urine

219

778

2.92

45.38

4.4

2.5

—

(3042936) Bacteria identified in Isolate by Culture

842

5179

1.80

45.26

2.7

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

229

836

2.85

45.14

4.3

2.4

—

(3015736) pH of Urine

1852

14044

1.61

44.94

4.4

3.6

6.30

6.24

1.20

989

7791

(3018095) Leukocytes [#/volume] in Urine

1745

13051

1.62

44.77

5.3

4.2

116.90

110.05

e6/l

0.11

1388

9440

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

222

804

2.87

44.40

1.5

1.4

563.95

594.01

mg/l

0.18

213

762

(3029937) Albumin [Presence] in Urine by Test strip

1386

9848

1.64

43.46

5.2

4.2

0.00

estimate

1.98

477

3354

(3028300) Cannabinoids [Presence] in Urine

227

844

2.80

43.22

4.4

2.4

—

(3027008) Opiates [Presence] in Urine

226

840

2.80

43.05

4.3

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1086

7262

1.69

43.05

2.0

1.8

1.73

1.43

mg/l

1.36

861

5674

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2835

23997

1.69

42.93

5.6

4.4

16.52

13.24

mm/h

17.54

2590

22319

(4198724) Urine methamphetamine measurement

103

6.70

42.89

2.1

3.9

—

(3045424) Erythrocytes [Presence] in Urine

361

1687

2.26

42.20

2.2

0.00

0.50

estimate

0.51

506

(36304419) Bacteria [Presence] in Urine

1350

9613

1.62

41.49

4.4

3.4

0.37

295.31

estimate

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

652

3810

1.86

41.02

11.2

8.5

120.60

120.96

g/l

0.16

639

3722

(3020891) Body temperature

372

1787

2.20

40.60

6.5

4.4

36.95

36.91

°c

1.12

367

1765

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

393

1930

2.15

40.57

1.6

1.7

1.65

1.54

g/l

1.42

327

1652

(3044640) Blood type and Crossmatch panel - Blood

1513

11132

1.59

40.24

3.2

2.6

—

(3045414) Leukocytes [Presence] in Urine

581

3296

1.90

40.02

2.3

2.2

0.00

0.01

estimate

0.78

659

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

7.84

39.98

1.9

2.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

375

1828

2.16

39.41

4.4

3.4

24.98

25.21

mmol/l

0.57

366

1768

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

198

719

2.85

39.37

1.4

1.3

4.06

3.81

mmol/l

2.01

183

675

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

404

2029

2.11

39.31

5.3

4.1

48.51

46.98

0.61

392

1997

(3010421) pH of Blood

276

1189

2.42

38.85

4.9

4.1

7.41

0.93

268

1175

(3024666) Lithium [Moles/volume] in Serum or Plasma

135

5.57

38.75

15.9

12.3

0.63

mmol/l

0.02

126

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

7.59

38.19

1.9

2.2

—

(3021901) Oxygen saturation in Capillary blood

214

829

2.67

37.59

3.3

3.0

89.30

89.27

0.02

209

806

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

465

2502

1.98

37.34

9.5

8.5

24.79

24.89

mmol/l

0.19

457

2486

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2785

23784

1.62

37.33

5.0

4.2

15.09

14.96

pmol/l

1.89

2505

21581

(3004119) Hemoglobin [Mass/volume] in Venous blood

462

2495

1.97

36.67

6.0

3.1

128.06

128.52

g/l

0.16

447

2424

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

146

5.22

36.59

1.8

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

444

2376

1.98

36.16

11.2

9.7

24.69

24.27

mmol/l

1.26

428

2322

(3008152) Bicarbonate [Moles/volume] in Arterial blood

452

2435

1.97

36.11

9.5

6.8

24.41

24.42

mmol/l

0.01

441

2332

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3434

31164

1.94

35.55

33.5

18.2

30.31

26.61

mg/l

9.11

3224

26197

(3003129) Base excess in Capillary blood by calculation

139

439

3.25

35.25

2.9

2.3

1.10

0.41

mmol/l

1.06

133

425

(3005719) IgG [Mass/volume] in Serum or Plasma

466

2565

1.93

34.88

2.6

2.9

10.18

10.72

g/l

1.83

425

2355

(3027944) Amphetamines [Presence] in Urine

207

826

2.59

34.24

3.8

2.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

861

5744

1.64

33.05

2.4

2.2

29.67

29.91

0.56

831

5578

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

287

1366

2.19

31.87

2.8

3.4

39.47

64.18

mg/l

1.30

231

1160

(3034860) Kappa light chains.free [Mass/volume] in Serum

287

1369

2.18

31.69

2.8

3.4

52.56

97.79

mg/l

0.59

230

1160

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1174

8505

1.55

31.50

3.0

2.5

—

(3013512) EKG study

1566

12086

1.50

31.05

5.0

4.0

1.00

0.73

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

242

3.87

30.81

1.2

1.3

2.16

2.21

mmol/l

0.15

227

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

262

1234

2.21

29.84

2.8

3.3

4.03

4.25

ratio

0.03

152

720

(3017732) Neutrophils [#/volume] in Blood

648

4124

1.69

29.49

5.4

3.3

5.47

4.70

e9/l

0.97

512

3510

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

203

869

2.41

28.90

1.4

1.5

0.24

g/l

0.05

193

826

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

175

700

2.57

28.80

1.8

1.5

12.75

34.37

e6/l

0.97

142

523

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

591

3691

1.71

28.79

5.3

3.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1014

7234

1.55

28.65

3.1

2.46

mmol/l

0.13

878

6470

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

176

709

2.55

28.54

1.9

1.5

1627.10

973.18

e6/l

0.31

150

564

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3182

28655

1.63

28.51

6.4

5.2

1.95

1.97

mu/l

0.52

2917

26177

(3008295) Osmolality of Serum or Plasma

121

403

3.07

28.10

1.4

1.3

281.10

276.39

mosm/kgh2o

0.84

294

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

262

1273

2.14

27.56

1.2

1.3

—

(3024928) Oxygen saturation in Venous blood

219

991

2.28

27.46

6.9

2.6

63.42

60.35

1.17

196

964

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

636

4098

1.66

27.44

12.3

7.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

528

3241

1.73

27.29

1.8

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

621

3983

1.67

27.25

3.1

2.8

9.07

9.22

umol/l

0.06

531

3539

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

139

511

2.78

27.03

7.4

6.6

11.79

12.18

mg/l

0.38

126

483

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

4.14

26.93

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

203

897

2.33

26.90

1.4

1.5

1.17

1.18

g/l

0.17

191

852

(3019550) Sodium [Moles/volume] in Serum or Plasma

3470

32099

1.82

26.72

39.9

22.0

139.24

139.60

mmol/l

9.98

3431

31442

(3011048) Pyruvate [Moles/volume] in Blood

27.93

26.65

1.3

1.2

81.48

100.31

umol/l

0.50

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

631

4090

1.65

26.52

4.8

5.1

32.90

32.56

0.30

429

2632

(3023103) Potassium [Moles/volume] in Serum or Plasma

3470

32154

1.80

25.80

39.9

22.2

3.99

4.00

mmol/l

0.98

3432

31440

(3016038) Potassium [Moles/volume] in Urine

250

3.54

25.65

1.2

31.47

35.20

mmol/l

0.85

221

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

167

4.13

25.05

1.7

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

167

4.13

25.05

1.7

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

254

3.48

25.05

1.6

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

360

2021

1.86

25.05

1.8

2.0

1.22

1.40

g/l

0.88

328

1837

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1892

15590

1.42

24.48

3.3

2.9

—

estimate

—

(3023420) DNA double strand Ab [Units/volume] in Serum

249

1242

2.07

24.42

1.6

6.29

6.66

iu/ml

0.08

296

(46235355) HIV 1 and 2 tests - Meaningful Use set

679

4572

1.59

24.22

2.0

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

593

3866

1.63

24.18

1.8

1.6

—

(3047181) Lactate [Moles/volume] in Blood

230

1128

2.10

23.59

7.5

6.1

1.58

1.32

mmol/l

2.16

200

1004

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

166

712

2.39

23.54

1.3

1.2

3.77

6.93

u/ml

—

(3002179) Metamyelocytes/Leukocytes in Blood

484

3014

1.69

23.53

4.2

1.15

0.72

1.06

213

946

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

251

3.40

23.35

1.6

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

102

344

3.02

23.23

2.0

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

259

1357

1.97

22.15

3.9

3.3

0.30

0.34

iu/ml

1.20

138

757

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

461

2879

1.68

22.11

5.7

4.0

1.21

1.22

mmol/l

3.64

411

2491

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

203

974

2.14

22.04

1.5

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

107

2642

0.39

21.82

2.1

2.0

3.52

3.57

ratio

0.15

2102

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

975

7244

1.46

21.58

5.2

4.2

260.57

539.30

ng/l

1.39

832

6073

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1640

1.87

21.40

1.8

2.3

4.17

4.19

g/l

0.15

250

1486

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1640

1.87

21.40

1.8

2.3

7.43

7.45

g/l

0.05

249

1487

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

1526

1.90

21.30

1.9

2.4

2.99

2.96

g/l

0.23

234

1373

(3043409) Potassium [Moles/volume] in Arterial blood

212

1051

2.08

21.13

6.1

4.1

3.84

3.91

mmol/l

1.22

212

1041

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

181

848

2.19

20.87

1.3

1.2

2.51

3.39

u/ml

0.56

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

3.85

20.86

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1639

1.86

20.84

1.8

2.3

3.69

3.76

g/l

0.29

248

1487

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

318

1820

1.81

20.70

6.7

5.0

1.69

1.60

0.75

298

1725

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

187

892

2.15

20.61

1.3

1.2

34.45

38.35

u/ml

0.08

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

30.20

20.54

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

262

1421

1.91

20.21

2.1

2.4

0.64

1.08

g/l

1.26

212

1205

(3017181) Myelocytes/Leukocytes in Blood

490

3177

1.62

20.20

4.5

4.3

1.00

0.92

0.28

203

1011

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

168

774

2.22

20.19

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

168

774

2.22

20.19

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

107

401

2.72

20.12

3.2

3.6

63.05

57.22

1.80

342

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1601

13105

1.38

20.08

5.2

4.1

0.24

0.39

estimate

0.21

458

3080

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

179

849

2.16

20.02

1.3

1.2

13.19

8.23

u/ml

0.20

131

(3015171) Extractable nuclear Ab [Units/volume] in Serum

220

1132

2.00

19.80

1.3

1.2

1.33

0.86

u/ml

0.16

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

864

6372

1.46

19.59

3.9

3.2

1.22

1.15

e6/l

0.23

524

3446

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1429

1.89

19.56

1.9

2.4

9.92

10.35

g/l

0.78

212

1262

(3025159) Blasts/Leukocytes in Blood

469

3036

1.62

19.42

5.0

4.5

0.19

0.15

0.09

174

808

(3008757) Leukocyte morphology finding [Identifier] in Blood

101

376

2.73

19.25

3.9

4.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

197

986

2.05

19.14

1.5

1.4

12.98

13.58

iu/ml

—

(3021440) Promyelocytes/Leukocytes in Blood

466

3029

1.61

18.95

4.6

4.3

0.08

0.11

0.60

179

865

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

139

3.93

18.74

2.5

1.5

4716908.14

1615829.90

iu/ml

—

(3044927) Protein electrophoresis panel - Urine

104

400

2.64

18.61

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

175

848

2.11

18.54

1.6

—

(40761536) Microorganisms panel - Urine sediment

410

2598

1.65

18.46

5.4

4.3

—

(3033658) Prothrombin time (PT) actual/Normal

1129

8815

1.40

18.45

6.2

4.4

84.88

85.90

0.67

1095

8633

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

251

1383

1.87

18.44

1.8

1.9

39.97

39.16

u/l

0.22

222

1210

(3037121) Protein [Mass/volume] in Urine

233

1256

1.91

18.31

3.1

3.4

574.55

414.51

mg/l

0.31

114

557

(3021589) Normoblasts [#/volume] in Blood

1733

14504

1.35

18.30

18.4

12.3

0.00

e9/l

0.29

1444

11800

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

358

2.72

18.26

2.8

—

(3052851) Hemolysis interference index of Serum or Plasma

191

971

2.02

17.79

4.1

3.6

1.60

1.74

index

0.14

492

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

107

427

2.55

17.78

1.6

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

107

431

2.52

17.45

1.6

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

107

433

2.51

17.28

1.6

1.3

—

(3004809) Band form neutrophils/Leukocytes in Blood

138

634

2.22

16.74

3.3

3.7

1.38

1.55

0.23

112

560

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

141

660

2.18

16.34

1.3

—

237.89

—

(3007164) IgA [Mass/volume] in Serum or Plasma

803

6024

1.42

16.20

1.6

1.5

2.62

2.64

g/l

0.06

491

3639

(3025468) Yersinia sp identified in Specimen by Organism specific culture

101

412

2.49

16.07

1.6

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

179

923

1.99

16.04

2.7

2.3

129.50

127.54

g/l

0.48

153

716

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

101

413

2.48

15.99

1.6

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

140

660

2.16

15.95

1.3

246.67

407.02

titre

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3492

33056

1.60

15.93

40.0

24.0

86.44

82.46

umol/l

4.52

3464

32611

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

354

2243

1.64

15.88

14.5

10.3

15.80

15.91

0.29

344

2166

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

415

2.47

15.83

1.6

1.3

—

(3042517) Benzodiazepines panel - Urine

12.94

15.64

2.3

2.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.55

15.62

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

106

453

2.38

15.26

4.3

6.2

6.84

7.43

mmol/l

1.19

383

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.90

15.24

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

181

3.24

15.16

1.2

153.28

138.87

nmol/l

0.98

181

(3009508) Creatinine [Moles/volume] in Urine

1472

12266

1.32

15.03

3.9

3.5

6.85

7.55

mmol/l

7.85

1197

10320

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1896

0.40

14.98

1.7

1.8

3.33

3.46

mmol/l

0.42

1346

(3004616) Nuclear Ab [Presence] in Serum

396

2.46

14.94

1.3

1.2

—

(1761868) Lipid panel - Serum or Plasma

857

10901

0.72

14.83

3.7

3.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

175

929

1.93

14.43

1.4

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.32

14.28

1.2

1.1

—

(40758558) Short blood count panel - Blood

1228

10028

1.33

14.25

8.7

6.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

172

912

1.93

14.24

1.2

73.18

106.42

titre

1.79

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.85

13.98

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

774

5902

1.39

13.96

4.2

3.3

2.34

1.99

e6/l

0.63

439

2963

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3442

32626

1.52

13.92

17.3

12.6

30.53

26.46

u/l

12.28

3342

31565

(3011397) Hemoglobin [Presence] in Urine by Test strip

1018

8150

1.34

13.37

4.8

3.9

0.50

0.10

—

115

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.01

13.33

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

188

1049

1.83

13.30

1.4

255.45

271.03

ug/g

0.48

102

639

(3016650) Hepatitis A virus Ab [Presence] in Serum

109

501

2.21

13.28

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

181

3.07

13.21

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

281

1759

1.64

13.20

2.9

3.4

4.36

4.45

pmol/l

0.64

238

1552

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.10

13.00

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

201

1155

1.78

12.91

2.1

2.3

0.00

g/l

-0.00

171

1006

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

101

459

2.23

12.66

2.3

2.2

27.82

23.07

mg/l

0.36

155

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

863

6791

1.35

12.61

1.4

1.3

1.34

1.63

u/ml

0.47

205

1782

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

186

1052

1.81

12.61

1.8

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

171

943

1.85

12.58

1.5

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

888

7021

1.34

12.57

5.9

4.8

—

(3025941) Bacteria identified in Stool by Culture

261

1624

1.65

12.56

1.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

130

654

2.02

12.55

1.6

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

173

959

1.84

12.52

1.6

—

(21494755) Public health laboratory ask at order entry panel

103

2084

0.48

12.48

1.3

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

468

3326

1.46

12.40

3.3

2.5

83.43

53.66

u/l

0.27

387

2803

(3022493) Free Hemoglobin [Mass/volume] in Plasma

153

3.16

12.18

1.1

4.6

74.75

70.44

mg/l

0.12

110

(3023410) Appearance of Cerebral spinal fluid

310

2.48

12.18

2.3

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

187

1073

1.78

12.09

2.1

2.4

0.00

g/l

-0.00

171

1005

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

455

3242

1.46

11.87

3.1

3.2

255.23

233.15

ng/l

0.38

418

2968

(3030981) Hyaline casts [#/volume] in Urine by Automated count

435

3076

1.47

11.81

2.7

2.5

0.61

0.48

e6/l

0.62

426

2963

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

136

3.26

11.75

1.1

504.07

206.16

ng/l

0.31

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

8.94

11.72

1.4

1.1

10.75

11.74

u/l

0.09

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

146

784

1.90

11.69

1.8

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1197

1.73

11.68

2.1

2.3

0.00

0.03

g/l

2.59

177

1068

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

182

1054

1.76

11.41

3.7

3.6

1.95

1.63

mg/l

2.88

162

951

(3020876) Protein [Mass/time] in 24 hour Urine

458

2.15

11.11

2.0

2.3

1.26

1.39

g/24h

0.23

270

(4035726) Immunohistochemistry procedure

417

2961

1.46

11.06

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

261

1677

1.60

11.04

7.3

5.2

0.89

0.87

0.49

248

1587

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

314

2106

1.53

11.01

2.5

2.4

12.77

20.60

au/ml

1.83

184

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

290

1911

1.56

11.01

1.4

1.3

45.37

55.55

au/ml

0.28

133

(3032057) Clostridioides difficile [Presence] in Stool

3.83

10.91

2.1

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

377

2.26

10.91

1.7

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

214

2.69

10.84

1.2

1.1

52.64

43.61

mg/l

0.32

178

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

192

2.78

10.79

1.1

—

(3019150) Specific gravity of Urine by Refractometry

960

7819

1.30

10.77

5.4

4.3

1.02

1.21

kg/l

0.50

696

5275

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

28.09

10.72

1.7

2.2

27.64

32.20

umol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.73

10.70

2.7

2.1

16.34

17.47

umol/l

0.15

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

21.50

10.67

1.1

—

mmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1104

9172

1.29

10.61

4.5

3.6

0.08

0.22

estimate

0.50

418

2903

(3039000) Anion gap in Blood by calculation

143

791

1.84

10.47

9.7

7.0

12.51

11.29

mmol/l

2.57

130

710

(3018572) Chloride [Moles/volume] in Blood

143

792

1.84

10.43

9.6

7.0

104.20

105.21

mmol/l

1.37

130

711

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

153

2.96

10.29

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

8.79

10.25

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

143

797

1.82

10.23

1.3

1.5

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3498

33564

1.46

10.21

47.9

27.2

92.16

91.42

15.90

3465

33114

(3010813) Leukocytes [#/volume] in Blood

3499

33576

1.46

10.20

48.2

27.3

7.43

6.86

e9/l

22.54

3441

32686

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3498

33567

1.46

10.17

49.3

27.9

38.64

40.25

20.97

3464

33102

(3007461) Platelets [#/volume] in Blood

3497

33557

1.46

10.16

48.1

27.3

243.81

243.57

e9/l

0.07

3444

32795

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

149

843

1.80

10.15

2.0

13.00

12.01

mg/l

0.50

140

774

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

351

2.25

10.09

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

351

2.25

10.09

1.4

1.2

19.68

52.09

u/ml

—

(3035941) MCH [Entitic mass]

3497

33565

1.45

10.06

47.9

27.2

30.48

30.41

1.28

3464

33116

(3026361) Erythrocytes [#/volume] in Blood

3497

33567

1.45

10.04

48.0

27.3

4.25

4.46

e12/l

87.73

3437

32684

(3000963) Hemoglobin [Mass/volume] in Blood

3497

33571

1.45

9.99

48.7

27.5

128.26

134.62

g/l

91.07

3462

33140

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

103

524

1.99

9.72

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

125

680

1.87

9.67

1.3

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.50

9.60

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

144

2.94

9.49

1.2

1.1

—

(3033099) Centromere Ab [Titer] in Serum

4.12

9.42

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3152

29824

1.31

9.38

28.7

18.0

77.08

76.91

ml/min/173m2

0.14

2992

27803

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

108

569

1.92

9.23

1.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

212

1354

1.60

9.23

2.5

2.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

116

626

1.88

9.22

1.4

1.2

31.71

51.27

u/ml

0.81

(3026389) Candida sp identified in Specimen by Organism specific culture

400

2.10

9.09

1.3

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

138

2.92

8.95

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

4.13

8.71

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

266

2.31

8.55

1.2

107.90

102.23

pmol/l

0.40

266

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

131

2.92

8.53

1.2

1.1

1582.37

1451.33

miu/ml

0.28

131

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

279

2.28

8.52

1.0

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1083

9172

1.25

8.51

3.0

2.9

369.44

356.84

umol/l

2.71

896

7989

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

480

1.96

8.47

1.4

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

307

2167

1.45

8.39

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

524

1.91

8.38

1.7

0.65

0.87

g/l

1.62

417

(3000494) Fungus identified in Specimen by Culture

523

4044

1.34

8.30

1.7

1.5

—

(3000012) Reticulocyte production index

109

600

1.84

8.19

1.7

2.1

0.88

0.87

0.05

418

(3035715) Granulocytes [#/volume] in Blood

106

580

1.85

8.12

3.6

3.4

4.43

4.32

e9/l

0.21

106

580

(4024509) Urine culture

236

1595

1.51

8.02

2.3

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

120

2.93

7.95

2.6

3.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

482

1.91

7.72

1.4

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

148

906

1.66

7.69

1.4

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

117

2.92

7.69

3.0

2.8

25.80

29.87

umol/l

1.30

(3020682) Albumin/Creatinine [Ratio] in Urine

1371

12015

1.22

7.63

4.5

4.2

13.38

9.25

mg/mmol

2.05

870

7680

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

135

2.76

7.53

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

576

4580

1.30

7.47

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

338

2.06

7.32

3.4

3.8

14.82

11.65

index

0.65

185

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.78

7.20

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

296

2.11

7.05

1.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

116

682

1.72

7.03

1.2

1.5

—

(3007463) Buprenorphine [Presence] in Urine

13.78

6.88

11.4

4.6

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

248

2.19

6.78

1.2

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

155

2.53

6.75

1.2

0.55

0.53

ratio

0.16

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.26

6.74

1.1

1.0

—

(3035933) Granulocytes/Leukocytes in Blood

116

692

1.70

6.69

3.5

3.4

58.55

58.75

0.06

116

692

(40768443) Skin Pathology biopsy report

218

1508

1.47

6.65

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

237

2.21

6.65

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

325

2.02

6.56

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1330

11756

1.20

6.50

3.7

3.5

70.08

50.43

mg/l

1.88

871

7738

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

2.89

6.46

1.1

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

157

1022

1.56

6.39

4.9

2.6

3.65

3.57

g/l

0.29

150

972

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

109

648

1.70

6.38

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

466

1.82

6.24

1.1

1.62

1.54

g/l

0.83

420

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

123

760

1.64

6.23

1.8

1.9

5.37

11.51

iu/l

0.36

298

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.33

6.14

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

239

2.15

6.12

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

369

1.91

6.10

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

2.84

6.09

1.1

1.2

3.14

4.33

umol/l

1.06

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

788

0.43

6.08

1.1

0.52

0.66

ratio

—

100

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

280

2.05

6.06

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

176

2.34

6.06

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

102

605

1.70

6.04

1.5

29.60

31.45

g/l

0.75

542

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

166

2.36

5.88

2.2

104.69

99.08

0.33

159

(3024891) Influenza virus A+B Ag [Presence] in Specimen

126

797

1.60

5.83

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

121

758

1.62

5.83

1.9

1.7

329.25

286.96

mu/l

0.50

109

703

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

238

2.12

5.79

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

238

2.12

5.79

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3135

30061

1.23

5.77

5.9

5.4

6.13

6.05

mmol/l

2.61

2788

27295

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

232

2.13

5.75

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

464

1.78

5.74

1.3

1.4

62.02

84.47

mu/l

0.42

414

(3016330) Potassium [Moles/time] in 24 hour Urine

5.18

5.69

1.2

—

(3017509) Phencyclidine [Presence] in Urine

6.10

5.68

2.7

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

227

2.13

5.66

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

122

772

1.60

5.65

1.6

1.4

9.68

8.57

u/l

0.35

621

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.74

5.60

1.2

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

222

2.13

5.56

1.2

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

104

636

1.65

5.53

1.5

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

509

1.73

5.45

1.7

2.2

32.33

32.54

0.17

504

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

129

2.49

5.44

3.4

2.7

0.60

0.61

mmol/l

0.60

129

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

355

2760

1.32

5.41

3.5

2.7

59.07

63.26

ml/min/173m2

1.10

169

1220

(3013336) Amino acids [Identifier] in Serum or Plasma

16.03

5.41

2.6

5.2

—

(3036180) Methadone [Presence] in Urine

16.03

5.41

1.4

3.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

173

2.27

5.38

2.2

1.7

1.77

2.50

u/field

0.57

126

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.19

5.38

1.0

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

266

2.01

5.36

1.4

1.3

21.69

25.14

u/l

0.33

214

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2402

25443

0.85

5.35

40.8

23.5

330.50

332.17

g/l

13.39

2385

25261

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

338

1.88

5.26

1.1

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.98

5.25

1.3

1.0

476.64

294.53

pmol/l

0.63

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

576

1.67

5.24

2.9

901.71

1558.76

u/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.59

5.16

2.4

2.6

0.50

0.54

u/field

0.07

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

151

2.33

5.16

2.5

50.04

51.75

umol/l

0.11

132

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

306

1.91

5.11

1.3

1.5

25.69

27.98

u/ml

0.15

(36660697) Celiac disease serology panel - Serum

312

2406

1.32

5.05

1.3

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.77

5.03

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

387

1.80

5.02

1.3

—

nmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

699

0.45

4.98

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

309

1.89

4.97

1.4

1.3

2.86

2.97

g/l

0.20

229

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

268

1.95

4.91

1.2

1.4

46.00

292.00

titre

—

(3023419) Bacteria identified in Sputum by Culture

502

1.69

4.91

2.0

2.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

428

1.74

4.87

1.2

1.3

298.51

305.32

pmol/l

0.08

361

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

852

0.51

4.85

1.4

1.2

1.54

1.49

g/l

0.52

852

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

566

1.64

4.83

1.5

1.4

180.88

153.17

au/ml

1.46

173

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.22

4.81

1.1

1.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

320

2503

1.30

4.69

1.5

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

309

1.86

4.65

1.4

1.3

0.34

0.42

g/l

1.11

228

(3027135) IgG subclass 1 [Mass/volume] in Serum

309

1.86

4.65

1.4

1.3

6.41

6.95

g/l

0.67

229

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.01

4.62

1.4

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.76

4.61

1.1

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

1029

9118

1.18

4.57

3.7

3.2

0.28

0.05

0.78

290

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

168

2328

0.71

4.56

1.3

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

8.20

4.56

1.6

1.0

1.89

2.82

—

(3017569) Oxygen content in Arterial blood

234

1.98

4.54

1.7

2.2

16.17

16.31

0.10

234

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

248

1.95

4.53

2.0

1.6

550.58

307.68

mu/l

1.05

196

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

110

719

1.55

4.51

6.1

5.9

482.11

2581.21

iu/ml

0.50

107

(3048689) Calprotectin [Mass/mass] in Stool

453

3718

1.25

4.50

2.5

2.4

163.82

155.76

ug/g

0.17

355

2962

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

108

706

1.55

4.43

1.3

1.8

0.87

0.86

nmol/l

0.03

589

(3017704) Immunofixation for Urine

216

2.00

4.40

1.6

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.07

4.40

1.7

1.6

—

(3012565) Volume of 24 hour Urine

156

2.19

4.39

2.0

2.6

2668.97

2024.84

0.90

134

(4146454) Self-monitoring of blood glucose

404

1.72

4.39

2.5

2.7

—

(3042631) Mycobacterium sp identified in Specimen

519

1.63

4.37

2.4

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

143

995

1.45

4.35

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

146

1022

1.45

4.31

4.4

3.3

1.77

1.65

mmol/l

0.56

139

992

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

475

1.66

4.30

1.3

0.51

0.30

nmol/l

—

(40768446) Kidney Pathology biopsy report

132

2.28

4.28

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

158

2.16

4.27

1.1

1.33

1.19

u/l

0.16

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

508

1.63

4.23

2.2

798.49

4985.62

u/l

2.28

195

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

283

1.85

4.23

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

244

1867

1.33

4.21

2.4

2.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

125

853

1.48

4.21

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

448

1.66

4.18

1.6

—

(4062490) Immunoglobulin typing, IgG

307

1.80

4.13

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

359

1.74

4.12

1.1

—

(44790049) Parainfluenza type 3 nucleic acid detection

467

1.64

4.07

1.4

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

467

1.64

4.07

1.4

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

467

1.64

4.07

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

467

1.64

4.07

1.4

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

391

1.70

4.05

1.6

2.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

302

1.80

4.04

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

302

1.80

4.04

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

302

1.80

4.04

1.8

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

154

1107

1.41

3.95

1.6

19.45

20.17

u/ml

0.03

224

(3028308) Erythrocytes [#/volume] in Pleural fluid

479

1.62

3.94

1.5

1.4

54212.24

70432.57

e6/l

0.26

274

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

269

1.83

3.90

1.2

125.00

168.12

titre

—

(3020393) Adenovirus Ag [Presence] in Stool

4.07

3.89

1.5

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3071

29661

1.17

3.88

7.8

6.9

40.40

39.99

mmol/mol

1.52

2776

27544

(3023199) Leukocytes [#/volume] in Pleural fluid

536

1.58

3.87

1.5

1.4

28234.61

1856.39

e6/l

1.21

377

(3052592) Norovirus Ag [Presence] in Stool

2.61

3.80

1.4

—

(3012441) Differential panel - Pleural fluid

453

1.62

3.78

1.4

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

131

923

1.43

3.78

3.7

2.5

215.20

199.15

0.97

123

878

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

12.02

3.76

1.0

1.50

1.00

u/field

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

12.02

3.76

1.2

2.2

1.73

2.39

g/l

—

(37021550) Renin [Units/volume] in Plasma --upright

2.65

3.72

1.3

42.36

70.11

mu/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

209

1.92

3.72

1.7

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.60

3.69

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

224

1.88

3.68

2.0

2.2

18.88

18.92

nmol/l

0.01

206

(3000475) Leukocytes [#/volume] in Synovial fluid

131

928

1.43

3.68

1.5

1.6

16214.36

14824.70

e6/l

0.15

100

643

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

334

1.72

3.67

1.2

64.79

73.08

u/l

0.24

294

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

210

1.91

3.67

2.2

1.9

106.64

122.55

ng/l

0.53

210

(3048929) Epstein Barr virus Ab [Presence] in Serum

124

871

1.44

3.65

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.12

3.64

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

116

2.25

3.63

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

123

2.20

3.60

1.2

1.3

10.03

376.83

ug/l

0.90

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

124

876

1.43

3.54

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1190

13011

0.88

3.49

2.0

1.9

1.48

1.35

mmol/l

4.37

978

10861

(3005322) IgE [Units/volume] in Serum or Plasma

238

1867

1.29

3.48

1.4

1.3

331.32

235.09

u/ml

0.73

219

1729

(3036489) Thrombin time

168

1254

1.36

3.48

2.9

2.2

21.71

21.33

0.40

155

1141

(3010838) Calcium [Moles/time] in 24 hour Urine

567

1.53

3.47

1.4

1.9

3.80

4.83

mmol/24h

2.39

489

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

584

1.52

3.45

1.3

311.23

267.97

u/ml

0.61

351

(3028433) Virus identified in Specimen by Culture

106

2.27

3.45

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

497

1.56

3.42

1.6

1.8

19.49

25.36

ug/l

0.85

488

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

259

1.79

3.42

1.0

301.31

317.50

ng/l

0.17

173

(42529406) Shigella sp [Presence] in Stool by Culture

125

891

1.42

3.41

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

124

884

1.42

3.39

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.39

3.39

1.2

1.6

0.45

0.39

ug/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

260

1.78

3.38

1.0

39.10

43.33

ng/l

0.35

171

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.10

3.37

1.2

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1029

0.64

3.36

1.9

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

7.01

3.36

1.6

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

261

1.77

3.34

1.0

502.89

685.38

ng/l

1.83

170

(3020717) Zinc [Moles/volume] in Serum or Plasma

156

2.00

3.24

1.4

14.06

23.01

umol/l

1.52

143

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

317

1.68

3.21

2.2

2.1

1.38

1.54

u/field

0.14

170

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

206

1.85

3.20

2.4

538.45

542.58

e6/l

0.02

170

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

200

1.86

3.15

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

104

2.22

3.15

2.3

1.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.25

3.12

1.2

1.5

14.77

15.91

pmol/l

0.36

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

413

1.58

3.12

1.4

1.3

1144.68

345.99

u/l

0.54

389

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

406

1.59

3.10

1.3

0.20

0.23

nmol/l

0.30

332

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.01

3.05

1.1

—

36.88

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

128

937

1.38

3.03

3.3

3.4

0.87

0.83

nmol/l

0.23

101

750

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

203

1.83

3.02

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

218

1.80

3.01

1.5

2.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

147

1.98

2.99

1.2

1.6

36.41

39.69

g/l

2.18

147

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

271

1.71

2.97

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.22

2.89

3.8

7.7

50.60

72.75

—

(40768800) Prostate Pathology biopsy report

907

0.65

2.87

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

297

1.66

2.86

1.9

1.5

0.22

0.29

nmol/l

0.92

223

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

102

2.16

2.86

1.2

1.1

14.35

9.95

pmol/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

917

0.65

2.84

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

237

1.74

2.84

1.1

1.5

15.72

13.98

umol/l

0.52

219

(3019832) Treponema pallidum Ab [Presence] in Serum

232

1866

1.26

2.83

1.8

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.65

2.79

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

556

1.47

2.77

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

277

1.67

2.77

1.2

1.3

—

titre

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

2.72

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.71

1.2

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.43

2.70

1.4

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

130

974

1.35

2.70

1.8

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

124

924

1.35

2.67

6.1

4.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.16

2.60

1.3

1.5

73.25

448.68

nmol/24h

0.66

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.61

2.57

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.06

2.56

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

215

1.73

2.55

1.4

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

132

1003

1.33

2.52

1.6

1.5

0.19

7.94

iu/ml

0.66

193

(3027923) C peptide [Moles/volume] in Serum or Plasma

201

1.75

2.52

1.2

1.4

1.85

1.12

nmol/l

1.76

141

(3005570) Glucose [Moles/volume] in Urine

342

1.56

2.45

1.8

2.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

203

1.73

2.44

1.5

11.11

6.95

u/l

0.47

165

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

104

770

1.36

2.37

1.4

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.26

2.37

1.8

2.0

341.80

343.50

ug/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

279

0.43

2.37

1.3

1.4

1.32

1.19

ratio

—

179

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

279

0.43

2.37

1.3

1.4

0.75

1.15

ratio

—

179

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

279

0.43

2.37

1.3

1.4

1.32

0.96

ratio

—

179

(3047189) Immunofixation for 24 hour Urine

183

1.75

2.35

1.6

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

191

1.73

2.33

1.2

22.07

19.41

u/l

0.24

157

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

276

0.43

2.31

1.3

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.48

2.27

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

325

1.55

2.27

1.1

—

2.63

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.07

2.26

2.1

1.5

—

0.31

—

(3002079) Sodium [Moles/time] in 24 hour Urine

127

1.90

2.25

1.2

1.3

147.79

179.74

mmol/24h

0.90

127

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

269

3188

0.83

2.24

1.6

1.4

—

(3033086) Enterovirus Ab [Titer] in Serum

5.56

2.21

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

210

1.67

2.19

1.4

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

453

0.57

2.19

3.9

4.0

39.73

34.94

u/ml

0.11

443

(3000330) Specific gravity of Urine by Test strip

224

1852

1.22

2.19

4.8

3.6

1.02

ratio

0.42

204

1700

(3010503) CD19 cells [#/volume] in Blood

203

1.68

2.17

2.5

2.2

150.71

158.08

e6/l

0.08

193

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.30

2.14

1.4

1.2

0.64

0.72

umol/24h

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

237

1977

1.21

2.13

2.0

1.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

167

1.74

2.11

1.1

1.2

616.91

398.45

u/l

0.24

154

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

210

1735

1.22

2.08

1.3

1.2

115.51

139.77

u/ml

0.35

607

(3023323) Follitropin [Units/volume] in Serum or Plasma

108

823

1.32

2.08

1.7

1.4

19.97

26.79

iu/l

1.53

690

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.71

2.06

1.2

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

245

1.60

2.06

1.4

1.5

—

(1002224) Polysomnography panel

1287

0.76

2.04

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.00

2.04

5.2

5.1

—

(3049717) Cytology report of Urine Cyto stain

189

1549

1.23

2.03

2.1

2.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.05

2.01

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

2.00

1.2

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

231

0.43

1.98

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

402

1.45

1.98

1.4

1.5

58.78

61.41

0.18

247

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

743

8112

0.90

1.98

3.0

3.3

0.73

0.80

ug/l

1.12

520

5471

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

313

1.51

1.95

2.2

2.4

11.04

35.06

iu/ml

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

4.55

1.94

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.57

1.94

1.2

1.0

—

(3022145) Colonoscopy Study observation

422

3727

1.15

1.93

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

113

1.86

1.91

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

2.25

1.90

2.4

2.3

4.37

4.15

ug/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

507

1.39

1.89

1.5

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.94

1.84

1.1

—

(3001556) Androgen free Index in Serum or Plasma

3.53

1.83

1.0

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.53

1.83

1.3

1.1

22.72

40.20

nmol/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

599

5438

1.12

1.79

1.4

1.3

33.13

34.23

iu/ml

0.05

189

1640

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

1.74

6.5

6.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.23

1.73

3.4

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

251

2152

1.18

1.72

2.2

2.0

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

163

1.66

1.71

1.3

1.4

61.82

63.75

0.11

131

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

179

1.62

1.69

2.1

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

179

1.62

1.69

2.1

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

179

1.62

1.69

2.1

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

179

1.62

1.69

2.1

1.7

—

(21494814) CD8 cells/Lymphocytes in Specimen

126

1.75

1.67

1.3

2.0

26.82

30.45

0.66

126

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

519

1.36

1.67

1.2

1.1

16.22

73.27

iu/ml

1.36

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

134

1.72

1.66

2.4

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

158

1303

1.22

1.65

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.93

1.64

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

427

1.39

1.64

1.2

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

150

1.67

1.63

1.6

1.7

4.81

9.76

nmol/l

0.62

126

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.57

1.61

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

237

0.50

1.60

1.4

1.5

—

(3016228) CD19 cells/cells in Blood

128

1.72

1.60

1.4

1.9

8.73

8.65

0.01

121

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

387

1.40

1.59

1.3

1.50

1.49

nmol/l

0.02

351

(3016750) Collection duration of Urine

206

1.56

1.59

2.3

2.1

506.18

496.49

min

0.21

146

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

672

1.30

1.59

1.3

297.79

224.63

miu/ml

0.52

273

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.00

1.59

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

554

5045

1.11

1.58

1.4

1.3

9.64

13.83

u/ml

0.64

194

1872

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

101

797

1.27

1.57

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

465

1.36

1.57

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

115

1.74

1.52

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.60

1.51

2.9

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

426

1.37

1.50

1.1

—

(3014891) Appearance of Pleural fluid

2.07

1.49

1.3

1.4

—

(3045788) Cell count panel - Pleural fluid

444

1.36

1.48

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

129

0.39

1.48

1.4

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

317

1.42

1.48

1.4

16.78

27.66

1.78

190

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

132

1.67

1.45

2.4

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

132

1.67

1.45

2.4

1.8

—

(3022621) pH of Urine by Test strip

304

2684

1.14

1.45

3.0

6.01

6.06

0.43

207

1896

(3042733) HLA Ab [Presence] in Serum

102

1.77

1.44

5.4

4.7

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

4.48

0.01

u/ml

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

353

1.39

1.43

1.4

1.3

144695.53

133625.59

e6/l

0.04

236

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

1.97

1.43

1.2

1.6

10.13

6.97

—

(3044242) Glucose [Moles/volume] in Arterial blood

249

1.45

1.32

1.7

2.0

7.71

8.23

mmol/l

0.45

249

(3023511) Choriogonadotropin [Units/volume] in Urine

225

1.47

1.31

1.5

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.78

1.28

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

448

1.32

1.27

1.1

1.2

3.12

3.84

u/ml

0.16

158

(3004775) Volume in Urine collected for unspecified duration

285

1.41

1.27

2.3

2.2

745.00

631.98

0.93

179

(3001186) Copper [Moles/volume] in Serum or Plasma

1.79

1.27

1.1

15.20

16.54

umol/l

0.52

(3008401) Mugwort IgE Ab [Units/volume] in Serum

423

0.68

1.25

1.0

1.1

1.13

1.06

u/ml

0.02

185

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

320

1.38

1.25

1.7

—

(3024263) Appearance of Synovial fluid

187

1.50

1.23

1.4

1.5

—

(4268621) Lupus anticoagulant assay

322

1.37

1.21

1.8

2.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

430

0.70

1.19

1.0

1.1

1.73

4.51

u/ml

2.07

229

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

231

1.43

1.17

2.1

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

198

1.47

1.16

2.0

2.7

42.76

38.51

0.81

109

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

190

1.48

1.16

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1427

13701

1.07

1.15

4.9

5.7

3.44

3.50

ug/l

0.03

1251

12356

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

110

1.64

1.15

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.85

1.13

1.2

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

103

1.65

1.12

1.3

1.9

2.36

1.81

ratio

0.56

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.73

1.08

4.0

7.9

6.47

5.46

kpa

0.40

(3018133) Calcium [Moles/volume] in Urine

1.87

1.07

2.3

2.02

2.91

mmol/l

1.45

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

2.12

1.05

1.0

1.1

—

19.90

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

137

1.54

1.05

2.9

2.2

851.50

734.41

e6/l

0.07

101

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

129

1.55

1.05

4.2

2.3

4.98

4.84

kpa

0.28

129

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

129

1.55

1.05

4.2

2.3

11.37

10.08

kpa

0.85

129

(3035880) pH of Pleural fluid

237

1.40

1.04

1.4

1.3

7.33

7.41

0.80

165

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.27

1.03

1.6

1.2

6.48

6.12

mmol/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.27

1.03

1.0

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

163

1.48

1.01

1.5

1.4

0.80

4.78

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

439

1.28

1.01

1.1

1.2

2.92

5.30

u/ml

1.29

210

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

422

3892

1.09

0.99

3.2

4.2

14.35

21.32

ug/l

0.74

333

3221

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1049

10972

0.94

0.98

3.9

4.6

21.84

22.03

0.14

525

5531

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.95

0.0

1.5

—

(3044889) 12 lead EKG panel

2327

22761

1.06

0.94

5.0

4.4

0.80

7229.07

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

427

1.27

0.92

3.1

3.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

498

0.76

0.91

1.3

1.6

1032.67

944.61

mu/l

0.16

413

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

746

1.20

0.90

1.1

12.07

7.52

eliau/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

2.07

0.89

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

100

849

1.18

0.88

2.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

662

0.80

0.88

1.3

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

119

1.52

0.88

1.3

1.2

41.71

39.34

g/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

712

1.20

0.87

1.2

24.58

43.44

u/l

1.97

615

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

300

0.70

0.87

1.0

0.75

0.27

u/ml

0.46

115

(3004451) EKG impression Narrative

229

1.36

0.86

1.3

1.2

—

(44806071) Cardiolipin IgM antibody measurement

1.94

0.84

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

205

1.37

0.83

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

205

1.37

0.83

1.3

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.88

0.81

1.2

2.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.79

0.0

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.78

0.0

1.3

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.77

0.76

37.0

10.2

0.28

0.21

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.77

0.76

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.54

0.75

2.4

1.3

21.99

25.37

g/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

100

1.50

0.72

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.55

0.71

2.2

2.4

1367.62

411.33

ug/l

0.29

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.92

0.70

1.8

1.3

—

(3044007) Cell count panel - Peritoneal fluid

118

1.44

0.69

3.4

1.9

—

(3008898) HLA-B27 [Presence]

853

1.15

0.68

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.85

0.68

1.2

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.54

0.67

1.2

1.7

—

0.64

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.79

0.66

2.2

1.7

1.29

1.45

umol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

338

0.77

0.64

1.4

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

392

0.79

0.62

1.1

3.31

1.46

u/ml

0.34

210

(3028717) Thiamine [Mass/volume] in Blood

1.63

0.62

1.0

1.3

64.75

65.88

ug/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.59

0.61

3.6

7.6

9.52

10.40

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

843

1.14

0.61

2.5

2.3

236.17

97.23

ug/min

1.41

498

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.48

0.60

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

356

0.78

0.60

1.0

1.1

1.23

2.73

eliau/ml

—

139

(3002256) Pathology report gross observation

426

4503

0.94

0.59

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

498

0.82

0.59

1.0

1.1

3.48

1.74

u/ml

0.29

270

(3014133) Dog dander IgE Ab [Units/volume] in Serum

343

0.79

0.58

1.0

1.1

10.56

2.59

u/ml

0.62

179

(40765089) Chromosome analysis panel - Blood by G-banded

1.48

0.57

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.67

0.56

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

409

4320

0.94

0.56

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

129

1429

0.90

0.56

1.1

—

(3045142) Bone marrow Pathology biopsy report

429

0.81

0.56

1.1

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

124

0.64

0.54

1.3

1.2

15.75

10.65

mm/h

—

124

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.58

0.54

1.3

2.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.58

0.54

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.46

0.54

1.2

1.1

80.71

88.73

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.52

0.52

1.0

1.5

—

(4195642) Thrombophilia screening test

406

1.18

0.51

1.1

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.50

0.51

1.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.41

0.51

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

206

1.26

0.50

2.9

3.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

436

1.17

0.49

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

119

1.35

0.48

3.0

2.1

843.75

18521.35

e6/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.49

0.47

20.9

13.4

3.43

5.39

mmol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

233

0.77

0.47

1.1

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.41

0.46

1.2

114.75

103.65

0.43

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.43

0.46

1.9

1.4

43.29

45.45

umol/l

—

(40768795) Lymph node Pathology biopsy report

319

0.81

0.44

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.56

0.42

2.8

2.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.40

0.42

1.0

1.2

—

(3006270) Folate [Moles/volume] in Blood

304

1.19

0.42

1.2

371.33

345.45

nmol/l

0.32

253

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.43

0.41

1.1

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.47

0.40

1.4

1.58

1.88

umol/24h

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.47

0.40

1.4

—

719.96

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.47

0.40

9.6

4.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

78.54

—

(3032773) Endomysium IgG Ab [Titer] in Serum

278

1.19

0.40

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

2.0

—

(3020650) Glucose [Presence] in Urine

115

1.31

0.38

1.8

0.00

0.05

estimate

0.80

115

(4212803) Bone marrow aspirate examination

1.39

0.38

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.35

0.37

1.6

1.4

10.71

9.12

ug/l

0.44

(3003740) Influenza virus B Ag [Presence] in Specimen

439

0.86

0.36

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

111

1023

1.09

0.36

2.3

2.2

—

(3024471) HLA-A [Type]

1.33

0.35

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

931

0.91

0.35

1.9

1.7

9.04

4.90

mg/l

0.97

701

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

489

1.13

0.35

3.1

2.7

4.89

931.26

u/ml

0.92

479

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.36

0.34

1.2

2.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

452

1.13

0.34

1.1

35.90

18.32

au/ml

—

100

(44813793) Dust mix specific IgE antibody measurement

177

0.79

0.33

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

256

1.17

0.33

2.5

2.7

28.95

33.39

mg/l

0.25

190

(1617658) Protocol used for examination of sentinel lymph nodes

198

0.81

0.32

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.33

0.32

1.2

1.4

80.17

87.96

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

165

0.79

0.32

6.4

6.7

12.11

125.65

ug/l

—

108

(3013727) Leukocytes other/Leukocytes in Blood

119

1.26

0.31

5.7

3.8

58.67

56.56

0.14

114

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

124

1159

1.07

0.30

1.9

38.85

40.97

nmol/l

0.42

117

1122

(3034426) Prothrombin time (PT)

1.29

0.30

1.2

1.3

27.08

28.82

0.66

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.29

0.30

1.1

1.3

26.00

30.37

—

(3002523) Influenza virus A Ag [Presence] in Specimen

440

0.89

0.29

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

131

1393

0.94

0.28

2.6

3.3

160.90

3863.06

u/ml

1.17

109

1207

(4034850) Laboratory test

1001

0.93

0.28

15.1

11.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

248

0.85

0.28

1.4

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

257

0.86

0.26

1.3

1.4

101.59

201.07

pmol/l

1.78

257

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

178

1.18

0.26

4.3

3.3

1.81

1.19

0.54

178

(3002619) Bacteria identified in Specimen by Culture

1.30

0.26

1.5

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

768

0.92

0.25

4.0

3.5

31.55

29.69

mg/l

0.17

536

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

330

1.12

0.25

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

226

1.15

0.24

2.3

1.5

71.23

87.60

umol/l

1.90

226

(3017446) Testosterone [Moles/volume] in Serum or Plasma

343

3322

1.04

0.24

2.8

2.3

12.01

13.33

nmol/l

2.18

294

2979

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.27

0.24

1.3

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

370

1.11

0.23

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

125

0.80

0.23

1.0

1.1

0.28

2.02

u/ml

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.28

0.23

1.0

1.1

70.48

75.69

ug/l

—

(3024932) HLA-DR beta [Type]

1.25

0.22

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.22

0.22

1.6

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.22

0.22

1.6

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.22

0.22

1.6

1.3

—

(3020491) Glucose [Moles/volume] in Blood

252

0.87

0.21

1.5

2.4

6.32

6.91

mmol/l

0.93

166

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

925

1.06

0.21

2.1

1.9

212.73

206.32

pmol/l

0.14

871

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

16.11

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

0.17

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

164

1.16

0.20

1.3

1.2

—

(3025577) Chromium [Mass/volume] in Blood

212

1.13

0.19

2.0

2.2

2.15

1.97

ug/l

0.18

177

(44806420) Estimation of glomerular filtration rate

302

0.89

0.19

2.5

2.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.18

0.19

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.18

0.19

1.2

1.0

9.83

51.18

iu/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

322

0.90

0.18

1.0

1.1

1.75

3.81

u/ml

1.21

148

(40768804) Tissue Pathology biopsy report

1290

12757

1.02

0.18

2.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

185

0.86

0.18

1.9

2.1

131.17

282.84

ug/min

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3003

30148

0.98

0.17

5.3

5.2

1.38

1.42

mmol/l

4.44

2676

27704

(3037692) Legionella sp identified in Specimen by Organism specific culture

129

1.16

0.17

1.1

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.20

0.16

1.4

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

819

1.05

0.15

2.3

3.5

403.52

927.19

u/ml

0.68

754

(3008536) Aspergillus sp Ab [Presence] in Serum

1.15

0.15

1.4

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

159

1.13

0.15

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

304

1.09

0.14

2.3

3.1

12.63

51.43

mg/l

1.43

238

(21494434) Karyotype in Bone marrow

347

0.92

0.14

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

520

0.94

0.13

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

202

2069

0.98

0.12

1.1

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

172

1.11

0.11

1.1

9.39

10.97

iu/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

153

1.11

0.11

1.1

1.2

—

(4015189) Microbial culture of sputum

1.16

0.11

4.1

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

208

0.91

0.10

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

154

1.10

0.10

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3103

30961

1.01

0.09

6.0

2.49

2.60

mmol/l

8.81

2781

28550

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

301

1.06

0.09

1.5

1.7

—

(40768793) Breast Pathology biopsy report

656

1.04

0.08

1.5

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.05

0.08

1.2

1.5

117.67

106.00

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

117

1.11

0.08

1.2

1.3

—

(4281824) Cell count and differential, peritoneal fluid

297

0.94

0.08

1.5

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2892

28858

1.01

0.08

4.6

4.4

1.41

1.30

mmol/l

9.78

2553

26233

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.05

0.07

1.4

1.18

mmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

105

0.86

0.06

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

962

1.02

0.04

1.7

—

30.85

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

393

0.97

0.04

1.9

3.5

144.80

19.80

nmol/l

0.41

385

(3042111) Morphology [Interpretation] in Bone marrow Narrative

664

0.98

0.04

1.2

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

121

1.07

0.03

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

230

0.96

0.03

1.1

1.9

10.26

10.70

umol/l

0.04

158

(3003694) ABO and Rh group [Type] in Blood

889

8860

1.00

0.03

1.3

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2536

25392

1.00

0.03

38.1

22.4

14.18

13.77

33.51

2515

25032

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

231

1.04

0.02

1.3

5.67

1.97

u/ml

0.32

138

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3035

30373

1.00

0.02

5.4

5.3

4.36

4.49

mmol/l

8.76

2720

28108

(4211845) Urine protein measurement

162

1.05

0.02

4.3

3.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

341

1.03

0.02

1.1

1.3

8.33

7.53

mmol/l

0.65

292

(40765096) Chromosome analysis panel by Banding

122

0.98

0.00

1.2

1.1

—

(40768441) Liver Pathology biopsy report

232

0.99

0.00

2.0

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

175

0.97

0.00

1.4

1.5

63.29

53.44

ug/l

0.53

175

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

149

1.01

0.00

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

151

0.99

0.00

4.7

3.8

—

(3025130) Human papilloma virus identified in Specimen

266

1.02

0.00

1.7

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

213

0.99

0.00

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

0.96

0.00

1.0

1.3

—

86.06

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

0.96

0.00

1.0

1.2

—

83.39

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.01

-0.00

3.0

3.2

—

81.45

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

3.57

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.62

—

(3051101) Glucose [Moles/volume] in Cord blood

0.94

-0.00

5.7

6.8

7.68

8.41

mmol/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1740.00

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

7.17

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.90

-0.00

1.4

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.90

-0.00

1.3

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.02

-0.00

1.2

1.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

3.72

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

107.00

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

40.60

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MYOPOTHUNS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_MYOPOTHUNS	2.128 [1.88, 2.4]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.218

During the follow-up period (1.1.1998 — 31.12.2019), 4593 out of 11033 females with G6_MYOPOTHUNS died.

Males

Parameter	HR [95% CI]	p-value
G6_MYOPOTHUNS	3.28 [2.85, 3.77]	< 0.001
Birth year	0.98 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 6141 out of 14096 males with G6_MYOPOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MYOPOTHUNS.

N-year risk	Females	Males
1	0.162%	0.382%
5	1.126%	2.7%
10	2.76%	7.574%
15	5.343%	13.817%
20	10.187%	21.645%

Relationships between endpoints

↥

Index endpoint: G6_MYOPOTHUNS – Other and unspecified myopathies

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified myopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints